Mea Kākau: John Stephens
Lā O Ka Hana: 2 Ianuali 2021
HōʻAno Hou I Ka Lā: 24 Iulai 2025
Anonim
GLEEVEC (IMATINIB) MOA
Wikiō: GLEEVEC (IMATINIB) MOA

Anter

He aha ka Gleevec?

ʻO Gleevec kahi lāʻau lapaʻau inoa inoa inoa inoa inoa. Hoʻohana ʻia ia e mālama i kekahi ʻano maʻi ʻaʻai koko i nā mākua a me nā keiki. Hoʻohana ʻia ʻo Gleevec e mālama i kahi ʻano o ka maʻi ʻaʻai ʻili a me kekahi ʻano o ka maʻi ʻaʻai gastrointestinal.

Loaʻa iā Gleevec ka lāʻau imatinib mesylate, no ka papa o nā lāʻau i kapa ʻia nā mea kāohi lāʻau ʻo tyrosine kinase.

Hele mai ʻo Gleevec ma ke ʻano he papa āu e lawe ai ma ka waha. Lawe ʻoe i ka lāʻau i hoʻokahi a i ʻole ʻelua mau manawa i ka lā, ke kaukaʻi ʻia i ke ana o ke kauka.

He aha kāna hana

Ua ʻae ka Food and Drug Administration (FDA) iā Gleevec e mālama i kekahi ʻano o nā maʻi maʻi koko, e like me:

  • ʻO ka chromosome-positive (Ph +) leukemia myeloid maʻi (CML) i nā mākua a me nā keiki
  • Ph + lepemia lymphocytic huehue (ALL) i hoʻi hou ʻia * * a i ʻole refractory * i nā mākua
  • ʻike hou ʻia ʻo Ph + ALL i nā keiki
  • myelodysplastic / myeloproliferative maʻi (nā iwi ʻāʻī iwi) i loko o nā mākua me ka platelet-loaʻa ulu mea receptor (PDGFR) gen rearrangements
  • hypereosinophilic syndrome a i ʻole leukemia eosinophilic mau i nā mākua
  • mastocytosis ʻōnaehana kolohe i nā mākua me ka ʻole o ka D816v c-Kit mutation

* Ua hoʻi mai ka maʻi ʻaʻai kope ma hope o ke kala ʻia ʻana, kahi hōʻemi o nā hōʻailona maʻi ʻaʻai a me nā ʻōuli. ʻAʻole i pane ka maʻi ʻaʻai Refractory i nā mālama maʻi ʻaʻai mua.


ʻAe ʻia ʻo Gleevec e mālama:

  • kahi ʻano maʻi ʻaʻai ʻili i kapa ʻia dermatofibrosarcoma protuberans (DFSP) i nā mākua
  • kahi ʻano o ka maʻi ʻaʻai gastrointestinal i kapa ʻia he Tum-positive gastrointestinal stromal tumors (GIST) i nā mākua

No nā kikoʻī, e ʻike i nā ʻāpana no “Gleevec no CML” a me “Nā hoʻohana ʻē aʻe no Gleevec.”

ʻO ka maikaʻi o Gleevec

Ua loaʻa ka maikaʻi o Gleevec i ka mālama ʻana i nā ʻano maʻi ʻaʻa koko.

I hoʻokahi hoʻokolohua hoʻokolohua, ua lawe nā mākua me CML hou i ka maʻi maʻamau iā Gleevec no ʻehiku mau makahiki. I kēia hui, 96.6% o ka poʻe i pane piha i ka lāʻau. ʻO kēia ka manaʻo ʻaʻole i loaʻa nā hunaola maʻi ʻino i loko o kā lākou koko, a ʻaʻohe o lākou ʻōuli o ke kanesa.

ʻO ka pane piha kahi ala e wehewehe ai i ka helu kūleʻa. I ka hui o ka poʻe i loaʻa ka chemotherapy maʻamau, 56.6% i pane piha.

Ua loaʻa ka maikaʻi o Gleevec i ka mālama ʻana i nā tumomoma stromal gastrointestinal (GIST) i loko o nā noiʻi maʻi. ʻO ka helu ola holoʻokoʻa ma kahi o ʻehā mau makahiki. ʻO kēia ka manaʻo o ka hapalua o ka poʻe i hoʻopaʻa ʻia i noho ma kahi o ʻehā mau makahiki ma hope o ko lākou hoʻomaka ʻana e lawe iā Gleevec. ʻO ka poʻe i lawe iā Gleevec ma hope o ka hana ʻoki ʻana e ola ana ma kahi o ʻelima mau makahiki ma hope o ka hoʻomaka ʻana o ka lāʻau.


E aʻo ai i ka maikaʻi o ka Gleevec i ka mālama ʻana i nā ʻano maʻi ʻē aʻe, e ʻike i ka ʻāpana "Nā hoʻohana ʻē aʻe no Gleevec".

ʻO Generic Gleevec

Loaʻa ʻo Gleevec ma ke ʻano he lāʻau inoa inoa inoa a me ke ʻano he generic form.

Loaʻa iā Gleevec ka lāʻau hana imatinib mesylate.

Nā hopena ʻaoʻao Gleevec

Hiki i ka Gleevec ke hana i nā hopena ʻoluʻolu a koʻikoʻi paha. Loaʻa i nā papa inoa aʻe kekahi o nā hopena ʻaoʻao nui i hiki ke hana ʻia i ka wā e lawe ana iā Gleevec. ʻAʻole pili kēia mau papa inoa i nā hopena āpau āpau.

No ka ʻike hou aku e pili ana i nā hopena pili o Gleevec, e kamaʻilio me kāu kauka a kauka paha. Hiki iā lākou ke hāʻawi iā ʻoe i nā ʻōlelo aʻoaʻo e pili ana i ka hana me nā hopena ʻē aʻe e hoʻonāukiuki paha.

Nā hopena ʻaoʻao hou aʻe

Hiki i nā hopena ʻaoʻao maʻamau o Gleevec ke hoʻopili:

  • pāhoehoe
  • ʻeha ka ʻōpū
  • luhi (nele o ka ikaika)
  • edema (ka pehu ʻana, maʻamau i kou mau wāwae, nā kuʻekuʻe wāwae, a i ʻole nā ​​wāwae a puni kou mau maka)
  • puʻupuʻu ʻili a ʻeha paha
  • nausea
  • ka luaʻi
  • hūwī

Hiki ke hele aku ka hapa nui o kēia mau hopena i loko o kekahi mau lā a i ʻole ʻelua mau pule. Inā ʻoi aku ke koʻikoʻi a i ʻole hele aku, e kamaʻilio me kāu kauka a kauka paha.


Nā hopena hopena koʻikoʻi

ʻAʻole maʻamau nā hopena koʻikoʻi mai Gleevec, akā hiki iā lākou ke hana. Kāhea koke i kāu kauka inā loaʻa nā hopena koʻikoʻi. Kāhea iā 911 inā manaʻo kou mau hōʻailona i ka hoʻoweliweli ola a i ʻole inā manaʻo ʻoe e loaʻa ana kahi pilikia olakino.

Hiki i nā hopena ʻē aʻe a me kā lākou mau hōʻailona ke hoʻohui i kēia:

  • ʻO ka paʻa ʻana o ka wai nui (ka nui o ka wai a wai paha) i loko a puni o kou puʻuwai, nā māmā (pleural effusion), a me ka ʻōpū (ascites). Hiki i nā ʻōuli ke hoʻohui pū:
    • ka mea i manaʻo ʻole ʻia, loaʻa ke kaupaona wikiwiki
    • ʻeha ka umauma
    • pokole o ka hanu
    • pilikia i ka hanu ʻana
    • pilikia i ka hanu ke moe ʻoe i lalo
    • ʻūhū maloʻo
    • ʻōpū pehu
  • Nā maʻi o ke koko, me ka anemia (nā pae haʻahaʻa o nā hunaola ʻulaʻula), neutropenia (nā pae haʻahaʻa o nā hunaola keokeo), a me ka thrombositopenia (nā pae haʻahaʻa o nā platelet). Hiki i nā ʻōuli ke hoʻohui pū:
    • luhi (nele o ka ikaika)
    • kōmi puʻuwai wikiwiki
    • pokole o ka hanu
    • nā maʻi pinepine
    • fiva
    • ʻū wale
    • gums kahe
    • ke koko i ka mimi a i ʻole ka noho
  • Hewa puʻuwai Congestive a me nā pilikia puʻuwai ʻē aʻe, e like me ka maikaʻi ʻole o ka puʻuwai hema. Hiki i nā ʻōuli ke hoʻohui pū:
    • loaʻa ke kaumaha i manaʻo ʻole ʻia
    • edema (hāhā o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae)
    • ka helu o ka puʻuwai a i ʻole ka ritim (kuʻi ka puʻuwai i wikiwiki loa, lohi, a i ʻole kaulike)
    • ʻeha ka umauma
    • pokole o ka hanu
  • Ka hōʻino o ke ake a me ke kūleʻa ʻole o ke ake. Hiki i nā ʻōuli ke hoʻohui pū:
    • nausea
    • pāhoehoe
    • nalo ʻai ʻole
    • ʻili ʻili
    • jaundice (kala melemele o kou ʻili a keʻokeʻo o kou mau maka)
    • edema (hāhā o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae)
    • ascites (hoʻoulu wai i kou ʻōpū)
    • ʻāpā pinepine
    • kahe pinepine ʻana o ke kahe
  • ʻO ka hemorrhage koʻikoʻi (kahe koko e kū ʻole), pinepine i kou ʻōpū. Hiki i nā ʻōuli ke hoʻohui pū:
    • koko i ka noho
    • noho ʻeleʻele a lōʻihi paha
    • luhi (nele o ka ikaika)
    • e kahe ana ke koko
    • e ʻū ana i ka lepo ʻeleʻele
    • nausea
    • ʻōpū o ka ʻōpū
  • Nā pilikia Gastrointestinal, me nā perforations (waimaka) i kou ʻōpū a i ʻole nā ​​ʻōpū. Hiki i nā ʻōuli ke hoʻohui pū:
    • nausea
    • ka luaʻi
    • ʻeha nui i kou ʻōpū
    • fiva
    • pokole o ka hanu
    • puʻuwai wikiwiki
  • Nā pilikia ʻili ʻino. Hiki i nā ʻōuli ke hoʻohui pū:
    • erythema multiforme (ʻulaʻula a palu paha, pinepine ma nā kapuwaʻi o kou mau wāwae a i ʻole nā ​​poho o kou mau lima)
    • ʻO Stevens-Johnson Syndrome (ke kuni; ʻeha ʻeha ma kou waha, ʻāʻī, maka, genitalia, a i ʻole ke kino holoʻokoʻa)
    • fiva
    • ʻeha ke kino
  • ʻO ka hypothyroidism (pae pae thyroid haʻahaʻa) i ka poʻe i hemo i kā lākou thyroid a ke lawe nei i kāu lāʻau hou. Hiki i nā ʻōuli ke hoʻohui pū:
    • luhi (nele o ka ikaika)
    • kōpaʻa
    • kaumaha
    • ʻano anuanu
    • ʻili maloʻo
    • loaʻa kaupaona
    • pilikia pilikia hoʻomanaʻo
  • Hoʻonui lohi i nā keiki. Hiki i nā ʻōuli ke hoʻohui pū:
    • ʻaʻole e ulu ana i ka uku maʻamau
    • ʻoi aku ka liʻiliʻi ma mua o nā keiki ʻē aʻe o kā lākou mau makahiki
  • Tumor lysis syndrome (ke hoʻokuʻu nā hunaola maʻi ʻino i loko o kou koko). Hiki i nā ʻōuli ke hoʻohui pū:
    • luhi (nele o ka ikaika)
    • nausea
    • ka luaʻi
    • pāhoehoe
    • ʻūpē mākala
    • ka puʻuwai puʻuwai maikaʻi ʻole (kuʻi ka puʻuwai i wikiwiki loa, lohi, a i ʻole maʻamau)
    • ka hopu ʻana
  • Poino hakuʻala. Hiki i nā ʻōuli ke hoʻohui pū:
    • emi iho ka mimiki ma mua o ka mau
    • edema (hāhā o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae)
    • luhi (nele o ka ikaika)
    • nausea
    • huikau
    • kahe koko kiʻekiʻe
  • Nā hopena i hiki ke alakaʻi i nā ulia kaʻa kaʻa. Hiki i nā ʻōuli ke hoʻohui pū:
    • ʻūpā
    • hiamoe
    • ʻike hihi ʻole

Nā kikoʻī hopena ʻaoʻao

E noʻonoʻo paha ʻoe i ka pinepine o kekahi mau hopena i hopena ʻia me kēia lāʻau, a i ʻole pili kekahi mau ʻaoʻao iā ia.Eia kekahi mau kikoʻī i nā hopena ʻē aʻe i hiki ʻole i kēia lāʻau ke kumu.

Ka hopena hoʻowali

E like me ka nui o nā lāʻau, hiki i kekahi poʻe ke loaʻa i kahi hopena maʻi ma hope o ka lawe ʻana iā Gleevec. Hiki i nā ʻōuli o ke ʻano ʻāpiki mālie ke hoʻopili pū i:

  • ʻāwīwī o ka ʻili
  • ʻumeʻume
  • flushing (hoʻomehana a ʻulaʻula i kou ʻili)

Kākaʻikahi ka hopena maʻi ʻino ʻoi aku ka paʻakikī akā hiki. Hiki i nā ʻōuli o ke kūpilikiʻi ʻāpiki loa ke hoʻopili pū me

  • angioedema (hāhā ma lalo o kou ʻili, maʻamau i kou mau lihilihi, nā lehelehe, nā lima, a me nā wāwae)
  • pehu o kou alelo, waha, a ʻāʻī paha
  • pilikia hanu

Kāhea koke i kāu kauka inā loaʻa iā ʻoe kahi maʻi maʻi ʻino loa iā Gleevec. Kāhea iā 911 inā manaʻo kou mau hōʻailona i ka hoʻoweliweli ola a i ʻole inā manaʻo ʻoe e loaʻa ana kahi pilikia olakino.

Nā hopena ʻaoʻao lōʻihi

ʻO kekahi o nā hopena i ʻike ʻia ma nā noiʻi maʻi hiki ke hana me ka hoʻohana lōʻihi o Gleevec. Hoʻopili kēia i nā pilikia puʻuwai, e like me ka puʻuwai puʻuwai congestive a me ka maikaʻi ʻole o ka puʻuwai hema.

Ma kahi noiʻi hoʻokolohua, ʻoi aku ma mua o 500 mau kānaka i lawe iā Gleevec no ka maʻi myeloid leukemia (CML) i ukali ʻia a 11 mau makahiki. ʻO ka poʻe i loko o kēia noi wā lōʻihi he nui nā hopena pili like i hōʻike ʻia i nā noiʻi pōkole. Eia nō naʻe, ua hoʻomaikaʻi ʻia kēia mau hopena i ka holo ʻana o ka manawa.

ʻIke ʻia nā hopena koʻikoʻi me ka hoʻohana wā lōʻihi:

  • nā maʻi koko koʻikoʻi (nā pae haʻahaʻa o nā hunaola ʻulaʻula, nā hunaola keokeo, a i ʻole nā ​​platelet) i nā kānaka ʻeono
  • nā pilikia puʻuwai, me ka puʻuwai puʻuwai congestive, i ʻehiku mau kānaka
  • ʻeono mau hihia o ka maʻi ʻaʻai hou, me myeloma he nui i hoʻokahi kanaka a me ke kanulau kolone i kekahi kanaka ʻē aʻe

ʻO nā hopena maʻa mau ka mea maʻamau i ka makahiki mua o ka mālama ʻana me Gleevec. Akā ʻo ka lōʻihi o ka lawe ʻana o ka poʻe iā Gleevec, ʻo ka liʻiliʻi ka nui o kēia mau hopena ʻaoʻao. ʻO kahi laʻana, i ka makahiki mua o ke aʻo, ʻekolu mau kānaka i loaʻa i nā maʻi koko koʻikoʻi, akā ma hope o ka lima o ka makahiki, hoʻokahi wale nō kanaka i hana.

I loko o kahi makahiki he ʻelima mau makahiki o ka poʻe me nā ʻōpū stromal gastrointestinal (GIST), ua kū ka 16% o ka poʻe i ka lawe ʻana iā Gleevec ma muli o ka hopena. Ua like nā hopena ʻaoʻao me nā mea i wehewehe ʻia ma ka noiʻi CML ma luna. Ua kuhikuhi ʻia he kanaha pākēneka o ka poʻe i ke aʻo ʻana i nā lāʻau ma lalo o ka lāʻau e hoʻomāmā ai i nā hopena ʻaoʻao.

Inā ʻoe hopohopo e pili ana i nā hopena lōʻihi loa o Gleevec, e kamaʻilio me kāu kauka. Hiki iā lākou ke kuhikuhi i nā ala e hōʻemi ai i kāu mau pilikia no kekahi hopena ʻaoʻao.

Nā hopena pili pili i ka maka

I nā noiʻi hoʻokolohua o Gleevec, ua loaʻa i kekahi poʻe nā hopena pili e pili ana i ka maka e like me ka pehu ʻana a me ka hihi o ka hihi.

ʻO ka ʻōpala a me ka pehu ʻana a puni nā maka kekahi o nā hopena ʻaoʻao maʻamau. Hiki i ka 74.2% o ka poʻe i lawe iā Gleevec i loaʻa i ka edema periorbital (ʻōhū o ka maka o ka maka).

Inā loaʻa iā ʻoe kēia hopena ʻaoʻao, hiki i kāu kauka ke kuhikuhi i kahi diuretic (i kapa ʻia he pil wai). Kōkua nā diuretics i kou kino e kāpae i ka wai keu a me ka paʻakai ke mimi ʻoe. Māmā kēia i ka hana ʻana o ka wai. Hiki i kāu kauka ke hoʻohaʻahaʻa i kāu lāʻau o Gleevec, inā pono.

Hoʻohui ʻia, ua hōʻike ʻia nā noiʻi hoʻokolohua a hiki i ka 11.1% o ka poʻe i lawe iā Gleevec i ʻike hihi. Inā he ʻike maka ʻole ʻoe, mai hoʻokele a hoʻohana i nā mīkini kaumaha. A e ʻike pono e haʻi aku i kāu kauka ʻaʻole hiki iā ʻoe ke ʻike akāka.

ʻO nā hopena ʻē aʻe pili pili maka ʻole ʻia e pili pū me:

  • maka maloʻo
  • maka maka wai
  • hoʻonāukiuki maka
  • conjunctivitis (pinepine i kapa ʻia he maka poni)
  • moku koko naha i ka maka
  • pehu o ka retina (kahi papa o nā kiko i ka hope o kou maka)

Inā lawe ʻoe iā Gleevec a loaʻa nā hopena pili e pili ana i ka maka, e kamaʻilio me kāu kauka. Hiki iā lākou ke ʻōlelo i nā ala e hōʻoluʻolu ai i kāu mau ʻōuli.

Lilo ka lauoho

ʻO ka lilo o ka lauoho (alopecia) kahi hopena hopena o ka lawe ʻana iā Gleevec.

Ua hoʻāʻo kahi noiʻi i ka hana a Gleevec i ka poʻe me ka chromosome-positive (Ph +) maʻi myeloid leukemia (CML). ʻEhiku pākēneka o kēia poʻe i lilo ka lauoho ma hope o ka lawe ʻana i ka lāʻau.

I loko o kahi noi ʻē aʻe, lawe nā kānaka iā Gleevec e mālama i nā tumomoma stromal gastrointestinal (GIST). Ma waena o 11.9% a me 14.8% o kēia poʻe i lilo ka lauoho. Ua ʻike pinepine ʻia kēia hopena i nā poʻe i lawe i nā koina kiʻekiʻe o Gleevec.

ʻO ka lilo o ka lauoho ma muli o ka mālama ʻana i ka maʻi ʻaʻaʻa he manawa pōkole ia. Inā pili ʻoe i kēia hopena ʻaoʻao, e kamaʻilio me kāu kauka. Hiki iā lākou ke ʻōlelo i nā ʻōlelo aʻoaʻo e kōkua iā ʻoe e hōʻemi i ka nalo ʻana o ka lauoho i kou wā e mālama ai.

ʻO Rash a me nā hopena ʻē aʻe o ka ʻili

Hiki i ka Gleevec ke hana i nā hopena ʻoluʻolu a koʻikoʻi hoʻi i kou ʻili.

ʻO nā hopena ʻili hou aʻe

ʻO nā rashes a me nā ʻili ʻili ʻē aʻe e ʻike pinepine ʻia i ka poʻe e lawe iā Gleevec.

I nā noiʻi hoʻokolohua, ua lawe ka poʻe iā Gleevec e mālama iā Ph + maʻi myeloid leukemia (CML). Aia i 40.1% o kēia poʻe i pākī a i ʻole nā ​​ʻili ʻē aʻe ma hope o ka lawe ʻana i ka lāʻau.

I nā noiʻi hoʻokolohua ʻē aʻe, ua lawe ka poʻe iā Gleevec no nā ʻōpū stromal gastrointestinal (GIST). Ma hope o ka lawe ʻana i ka lāʻau, a hiki i ka 49.8% o kēia poʻe i loaʻa i nā rashes a i ʻole nā ​​ʻili ʻē aʻe. Pākuʻi ʻia kēia mau mea:

  • ʻili ʻana o ka ʻili
  • ʻili maloʻo
  • ʻiliʻili (kahi aniani bluish i ka ʻili)
  • nā maʻi o nā lauoho follicle (ʻeke ma lalo o kou ʻili e paʻa ana i nā aʻa o kou lauoho)
  • erythema (ʻulaʻula o ka ʻili)
  • purpura (poni-ʻula nā kiko ma ka ʻili)

Ua maʻa mau kēia mau hopena i nā poʻe i lawe i nā kaupaona kiʻekiʻe o Gleevec.

Inā ʻoe hopohopo e pili ana i nā huehue a i ʻole nā ​​ʻili ʻili ʻē aʻe e pili ana iā Gleevec, e kamaʻilio me kāu kauka. Hiki iā lākou ke ʻōlelo i nā ala e hōʻoluʻolu ai i kāu mau ʻōuli.

Nā hopena ʻili koʻikoʻi

I nā noiʻi hoʻokolohua, laha ʻole ka hopena o ka ʻili koʻikoʻi i ka poʻe i lawe iā Gleevec. Aia a 1% o ka poʻe i lawe i kēia lāʻau i loaʻa i ka ʻili koʻikoʻi. ʻO nā laʻana o nā hopena ʻili e pili ana i ka lāʻau.

  • ʻO Stevens-Johnson Syndrome (ke kuni; ʻeha ʻeha ma kou waha, ʻāʻī, maka, genitalia, a i ʻole ke kino holoʻokoʻa)
  • exfoliative dermatitis (kaʻiliʻili i nā ʻāpana nui o kou kino)
  • ʻūhū vesicular (nā palapū liʻiliʻi a me kahi hua nui)

Hiki i nā rashes a me nā palapū ke ʻeha loa. A inā ʻaʻole mālama ʻia lākou, hiki iā lākou ke hei i nā bacteria a alakaʻi i nā maʻi nui. No laila inā ʻoe e lawe nei iā Gleevec a loaʻa kahi hū a i ʻole nā ​​palapū me kahi kuni a maikaʻi ʻole ʻoe, e haʻi koke i kāu kauka E haʻi pū kekahi i nā ʻili ʻē aʻe i loaʻa iā ʻoe.

Nā hopena e pili ana i ka hoʻokele

I nā noiʻi hoʻokolohua, ua loaʻa i kekahi poʻe i lawe iā Gleevec nā hopena i hiki ke hoʻopili i ko lākou hiki ke hoʻokele. Pākuʻi ʻia kēia mau mea:

  • dizziness: a i ka 19.4% o ka poʻe
  • ʻike hihi: a hiki i 11.1% o ka poʻe
  • luhi: i ka 74.9% o ka poʻe

Hoʻopili paha kēia mau hopena i kou hiki ke hoʻokele a hoʻohana paha i nā mīkini kaumaha. Ua loaʻa nā hōʻike o nā ulia kaʻa kaʻa e nā poʻe i lawe iā Gleevec. No laila pono ʻoe e akahele i ka wā e hoʻokele a hoʻohana ʻana paha i nā mīkini i ka lawe ʻana iā Gleevec.

Hoʻoiho hōʻeha (ʻaʻole kahi hopena)

ʻAʻole i hōʻike ʻia ka hōʻeha hōʻeha lohi i nā noiʻi maʻi o Gleevec.

ʻO kekahi ʻano o ka mālama ʻana i ka maʻi ʻaʻai, e like me ka radiation a me ka chemotherapy, e hoʻonāwaliwali paha i kou ʻōnaehana pale. Hiki i kēia ke hōʻolo mālie i nā hōʻeha.

Inā ʻoe hopohopo e pili ana i ka hoʻōla hōʻeha ʻana, e nīnau i kāu kauka inā he ʻoi aku kou kiʻekiʻe i kēia pilikia ma muli o kāu ʻano olakino.

Kanesa maʻi ʻaʻai (ʻaʻole paha he ʻaoʻao)

ʻAʻole i hōʻike ʻia ka maʻi ʻaʻai o ke ake ma ke ʻano he hopena ʻaoʻao i ka noiʻi olakino o Gleevec. Eia nō naʻe, ua hōʻino ʻia ke akepaʻa i ka hoʻohana pōkole a me ka wā lōʻihi o Gleevec. ʻO kekahi mau hihia o ka hōʻino ʻana o ke ake a ua alakaʻi i ka maikaʻi ʻole o ke ake a me ka lawe ʻana o ke ake.

ʻIke pinepine ka hōʻino o ke ake i ka wā e nānā ai nā kauka i nā enzymes (nā protein ponoʻī) i hana ʻia i ke ake. ʻO nā pae enzyme i ʻoi aku ka kiʻekiʻe ma mua o ka maʻamau ke lilo i hōʻailona o ka hōʻino o ke ake.

ʻO kekahi mau hōʻailona kino o ka hōʻino o ke ake pū kekahi:

  • nausea
  • pāhoehoe
  • nalo ʻai ʻole
  • ʻili ʻili
  • jaundice (kala melemele o kou ʻili a me nā keʻokeʻo o nā maka)
  • edema (hāhā o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae)
  • ascites (hoʻoulu wai i kou ʻōpū)
  • ʻāpā pinepine
  • kahe pinepine ʻana o ke kahe

I ka wā o nā noiʻi maʻi ʻana, a hiki i ka 5% o ka poʻe me ka leukemia myeloid maʻi (CML) i kiʻekiʻe loa nā pae o ka ʻenema ate i ka wā o Gleevec lapaʻau. Hiki i ka 6.8% o ka poʻe me nā ʻōpū stromal gastrointestinal (GIST) i loaʻa i nā kiʻekiʻe nā ʻenemene kiʻekiʻe kiʻekiʻe i ka wā o ka lapaʻau. A i ka 0,1% o ka poʻe i lawe iā Gleevec i loaʻa ʻole ke akepaʻa o ke ake.

ʻOiai ʻoe e lawe iā Gleevec, e nānā kāu kauka pehea e holo nei kou ake. Inā loaʻa iā ʻoe kahi hōʻailona o ka hōʻino o ke ake i ka wā e lawe ana iā Gleevec, hiki i kāu kauka ke hōʻemi i kāu lāʻau. Pale aku paha kēia i ka hōʻino e hiki ai i ke kō ʻole o ke ake.

Nā hopena ʻē aʻe i nā keiki

ʻO nā kamaliʻi i loko o nā noiʻi hoʻokolohua nāna i lawe iā Gleevec he mau ʻaoʻao ʻē aʻe i like loa me nā poʻe mākua. Akā ua loaʻa i nā mea noiʻi kēia mau hoʻokoe.

  • ʻoi aku ka liʻiliʻi o nā keiki i ka ʻeha a me ka ʻeha o ka iwi ma mua o ka ʻelemakule
  • ʻO ka edema (ka pehu o nā wāwae, nā kuʻekuʻe wāwae, nā wāwae, a me nā wahi a puni nā maka) ʻaʻole i hōʻike ʻia i nā keiki

ʻO nā hopena i hōʻike pinepine ʻia e hōʻike ʻia i nā keiki ʻo ka nausea a me ka luaʻi. ʻO nā hopena ʻino nui e like me nā haʻahaʻa haʻahaʻa o nā hunaola keokeo a me nā pā.

Inā loaʻa i kāu keiki kēia mau hopena ʻaoʻao, e kamaʻilio me kāu kauka o kāu keiki e pili ana i nā ala e mālama ai iā lākou.

Gleevec no CML

Ua ʻae ka Food and Drug Administration (FDA) iā Gleevec no kekahi poʻe me ka Philadelphia chromosome-positive (Ph +) leukemia myeloid mau (CML). ʻO ka chromosome Philadelphia he chromosome helu 22 me kahi kīnā. Loaʻa ka poʻe me Ph + CML i kahi loli kikoʻī i kā lākou DNA e hana ai i nā hunaola keokeo he nui e hana.

Māhele ʻia ʻo CML i ʻekolu mau hanana:

  • Pae kau. ʻO kēia ka pae mua o CML. Hoʻomaopopo ʻia ka hapanui o ka poʻe me CML i ka wā hoʻomau. Mālie nā ʻōuli, inā aia kekahi.
  • ʻĀina wikiwiki. I kēia pae ʻelua, piʻi ka nui o nā hunaola maʻi ʻaʻai i loko o kou koko. Loaʻa paha iā ʻoe nā hōʻailona hou aku, e like me ke kuni a me ka pohō kaumaha.
  • ʻAha pōpilikia pahū. I kēia pae holomua loa, ua pālahalaha ʻia nā hunaola maʻi ʻaʻai i loko o kou koko i nā ʻōpala a me nā ʻaʻa ʻē aʻe. ʻOi aku paha ke koʻikoʻi o kāu mau hōʻailona.

Ua ʻae ʻia ʻo Gleevec e mālama iā Ph + CML hou i hōʻike ʻia i ka manawa mau i nā poʻe o nā makahiki āpau.

Ua ʻae pū ʻia e mālama iā Ph + CML i ka wā pōkole, i hōʻeleu ʻia, a i ʻole ʻūlū pōpilikia pahū no ka poʻe i loaʻa ʻole ka lāʻau kūleʻa me ka interferon-alpha therapy. ʻO Interferon-alpha kahi lāʻau i hoʻohana pinepine ʻia i ka wā ma mua e mālama iā CML. Ua hoʻololi ʻia e nā lāʻau e like me Gleevec i hōʻike ʻia e ʻoi aku ka maikaʻi.

Ka hoʻokō ʻana

I loko o kahi makahiki he ʻehiku makahiki noiʻi maʻi, ʻo ka helu ola no nā mākua i lawe iā Gleevec no Ph + CML i hōʻike hou ʻia he 86.4%. ʻO ka manaʻo o kēia ua ola ka 86.4% o nā mākua no ʻehiku mau makahiki ma hope o ka hoʻomaka ʻana e lawe iā Gleevec. Ua hoʻohālikelike ʻia kēia me 83.3% o ka poʻe i lawe i nā lāʻau chemotherapy maʻamau.

I kahi hoʻokolohua hoʻokolohua, ʻo nā poʻe i hoʻāʻo mua i ka interferon-alpha no CML i lawe iā Gleevec. Ua pane piha kekahi o kēia poʻe i ka mālama ʻana iā Gleevec. ʻO kēia ka manaʻo ʻaʻole i loaʻa nā hunaola maʻi ʻino i loko o kā lākou koko, a ʻaʻohe o lākou ʻōuli o ke kanesa. Eia ka nui o ka poʻe me CML i pane piha i ka lawe ʻana iā Gleevec:

  • 95% o ka poʻe i ka pae mau
  • 38% o ka poʻe i ka pae wikiwiki
  • 7% o ka poʻe i ka wā pilikia pahū

Ua hoʻokomo pū ʻia ka noiʻi maʻi me nā keiki me Ph + CML i ka pae mau. I ka hui i lawe iā Gleevec, 78% o nā keiki i pane piha i ka lāʻau.

Nā hoʻohana ʻē aʻe no Gleevec

Hoʻohui ʻia me ka leukemia myeloid mau (ʻike ma luna), ua ʻae ka Food and Drug Administration (FDA) iā Gleevec e mālama i kekahi mau ʻano ʻē aʻe.

Gleevec no ka maʻi leukemia lymphocytic huehue (ALL)

Ua ʻae ʻia ʻo Gleevec e mālama iā:

  • ʻO ka chromosome-positive (Ph +) leukemia lymphocytic huikau (ALL) i hoʻi hou ʻia * * a i ʻole refractory * i nā mākua
  • ʻike hou ʻia ʻo Ph + ALL i nā keiki ke hoʻohana ʻia me chemotherapy

* Ua hoʻi mai ka maʻi ʻaʻai kope ma hope o ke kala ʻia ʻana, kahi hōʻemi o nā hōʻailona maʻi ʻaʻai a me nā ʻōuli. ʻAʻole i pane ka maʻi ʻaʻai Refractory i nā mālama maʻi ʻaʻai mua.

I loko o kahi noiʻi hoʻokolohua, 19% o nā mākua me ka hoʻi hou ʻana a i ʻole refactory ALL i lawe iā Gleevec i pane piha i ko lākou koko i ka lāʻau. ʻO kēia ka manaʻo ʻaʻohe o lākou hōʻailona o ka maʻi ʻaʻai.

Ua nānā pū kekahi kahi noiʻi hoʻokolohua i nā keiki me ALL ka poʻe i lawe iā Gleevec a ua loaʻa iā chemotherapy. No 70% o nā keiki, ʻaʻole iʻoi aku ka maikaʻi o ko lākou maʻi ʻaʻai no ʻehā mau makahiki.

Gleevec no nā ʻano maʻi ʻaʻai ʻē aʻe

Ua ʻae ʻia ʻo Gleevec e mālama i nā ʻano ʻē aʻe o nā maʻi maʻi koko, e like me:

  • Nā maʻi Myelodysplastic / myeloproliferative (nā maʻi ʻaʻa pū iwi) i nā mākua me nā receptor ulu ulu i loaʻa i ka platelet (PDGFR). I kahi noi hoʻokolohua liʻiliʻi, 45% o ka poʻe i mālama ʻia me Gleevec i pane piha i ko lākou koko i ka lāʻau. ʻO kēia ka manaʻo ʻaʻole i loaʻa i nā hunaola maʻi ʻaʻai i loko o kā lākou koko, a ʻaʻohe o lākou ʻōuli o ka maʻi ʻaʻai.
  • ʻO ka Hypereosinophilic Syndrome a me / a i ʻole leukemia eosinophilic mau i nā mākua, me nā poʻe me ka FIP1L1-PDGFRα fusion kinase. I nā noi olakino liʻiliʻi, 100% o ka poʻe me ka mutation gen PDGFR nāna i lawe iā Gleevec i pane piha i ko lākou koko i ka lāʻau. Ma waena o 21% a me 58% o ka poʻe me ka ʻole o ka mutation a i ʻole me kahi kūlana mutation ʻike ʻole ʻia i lawe iā Gleevec i pane piha i loko o kā lākou koko.
  • ʻO ka mastocytosis ʻōnaehana aggressive i nā mākua me ka ʻole o ka D816v c-Kit mutation. I kahi noi olakino liʻiliʻi, 100% o ka poʻe me ka FIP1L1-PDGFRα fusion kinase mutation i mālama ʻia me Gleevec i pane piha i ka lāʻau.

Gleevec no ka maʻi ʻaʻai ʻili

Ua ʻae ʻia ʻo Gleevec e mālama iā dermatofibrosarcoma protuberans, kahi ʻano maʻi ʻaʻai ʻili ʻole o ka ʻili, i nā mākua. Ua ʻae ʻia no ka poʻe i loaʻa i ka maʻi ʻaʻai.

  • ʻaʻole hiki ke hoʻohana ʻia
  • ua hoʻi mai ma hope o ka lapaʻau ʻana
  • metastatic (ua hoʻolaha ʻia i nā ʻāpana ʻē aʻe o ke kino)

Ua mālama ʻia kahi poʻe liʻiliʻi me Gleevec no kēia ʻano i nā noiʻi maʻi. ʻO kēlā poʻe i lawe iā Gleevec, he 39% ka pane i ka lapaʻau. ʻO kēia ke kumu o kahi biopsy o ka ʻili (wehe a hoʻāʻo ʻana i kahi hāpana ʻili o ka ʻili) i hōʻike ʻole i nā ʻōuli o ke kanesa.

Gleevec no ka maʻi ʻaʻai gastrointestinal

Ua ʻae ʻia ʻo Gleevec e mālama iā Kit-positive gastrointestinal stromal tumors (GIST) i nā mākua i hiki ʻole ke hana a metastatic paha (ua hoʻolaha ʻia i nā ʻāpana ʻē aʻe o ke kino). ʻAe ʻia ʻo Gleevec e mālama iā GIST i nā mākua i loaʻa i ka ʻokiʻoki e wehe i nā tumors. Hoʻohana ʻia kēia ʻano lapaʻau (adjuvant treatment) e pale i ka maʻi ʻaʻai mai ka hoʻi ʻana ma hope o ke kaha ʻana.

I nā noiʻi maʻi, ʻo ka poʻe me GIST i hiki ʻole ke wehe ʻia i ka lāʻau i lawe iā 400 a i ʻole 800 mg o Gleevec. Ua ola lākou ma kahi o ʻehā mau makahiki.

ʻO nā kānaka ʻē aʻe me GIST i hana ʻoki ʻia. Ma waena o 14 a me 70 mau lā ma hope, ua hoʻomaka lākou e lawe iā Gleevec i ke aʻo ʻana. Loaʻa iā lākou ma kahi o 60% ka makaʻu haʻahaʻa o ka make ʻana a i ʻole ke hoʻi ʻana o ka maʻi ʻaʻai i loko o 12 mau mahina. Hoʻohālikelike ʻia kēia i ka poʻe i lawe i kahi placebo (lapaʻau me ka lāʻau hana ʻole).

Hoʻohana ʻia ka inoa lepili no Gleevec

Ma waho aʻe o nā hoʻohana i helu ʻia ma luna, hoʻohana ʻia ʻo Gleevec i ka lepili inoa no nā hoʻohana ʻē aʻe. ʻO ka hoʻohana ʻana i ka lāʻau lapaʻau ʻole ka wā hoʻohana ʻia kahi lāʻau i ʻae ʻia no ka hoʻohana hoʻokahi i kuhikuhi ʻia no kahi mea ʻē aʻe i ʻae ʻole ʻia.

Hiki ke hoʻohana ʻia ʻo Gleevec i ka lepili no nā maʻi ʻē aʻe, e like me:

  • maʻi ʻaʻai prostate, e like me kahi noiʻi 2015
  • melanoma, e like me ka National Comprehensive Cancer Network lapaʻau lapaʻau
  • ʻano 1 diabetes, e like me ka hoʻokolohua hoʻokolohua 2018

Eia nō naʻe, ʻaʻole nui ka noiʻi e pili ana i ka hana a Gleevec i loko o ke kanaka me kēia mau ʻano. Pono nā noi hou e hoʻoholo inā kōkua ʻo Gleevec i ka mālama ʻana i kēlā me kēia ʻano.

Gleevec no nā keiki

Ua ʻae ʻia ʻo Gleevec e lapaʻau ʻia no nā keiki me nā ʻano aʻe:

  • ʻike hou ʻia ʻo Philadelphia-positive (Ph +) leukemia myeloid mau loa (CML) i ka wā mau (ka pae mua o ka maʻi)
  • ʻike hou ʻia ʻo Ph + huehue lymphocytic leukemia (ALL) ke hoʻohana ʻia me chemotherapy

ʻAe ʻia ʻo Gleevec e hoʻohana i nā keiki o nā makahiki āpau. Eia nō naʻe, ʻaʻole i loaʻa nā noiʻi ʻana e pili ana i ke ʻano palekana a maikaʻi paha o Gleevec i nā keiki ma mua o ka makahiki 1.

Kālā Gleevec

E like me nā lāʻau āpau, hiki ke hoʻololi ke kumukūʻai o Gleevec.

ʻO ke kumukūʻai maoli āu e uku ai ma muli o kāu ʻinikua uhi a me ka hale kūʻai lāʻau lapaʻau āu e hoʻohana ai.

Kōkua kālā a me nā ʻinikua

Inā makemake ʻoe i kākoʻo kālā e uku no Gleevec, a inā ʻoe e kōkua i ka hoʻomaopopo ʻana i kāu ʻinikua uhi, loaʻa ke kōkua.

Hāʻawi ʻo Novartis Pharmaceutical Corporation, ka mea hana o Gleevec, i kahi papahana i kapa ʻia ʻo Novartis Oncology Universal Co-pay Program. No ka ʻike hou aku a e ʻike inā ua kūpono ʻoe no ke kākoʻo, kāhea iā 877-577-7756 a i ʻole kipa i ka pūnaewele pūnaewele.

Nā mea hana Gleevec

ʻO ka lāʻau Gleevec i kuhikuhi ʻia e kāu kauka e pili ana i nā kumu he nui. Pākuʻi ʻia kēia mau mea:

  • ke ʻano a me ke koʻikoʻi o ke ʻano āu e hoʻohana nei iā Gleevec e mālama ai
  • makahiki
  • ke kaupaona (no nā keiki)
  • alo o ka hoʻololi gen
  • nā kūlana olakino ʻē aʻe āu
  • nā lāʻau ʻē aʻe āu e ʻai ai
  • nā hopena ʻē aʻe i loaʻa iā ʻoe

ʻO ka mahele lāʻau e loaʻa iā ʻoe e pili ana i kāu maʻi ʻaʻai. No kekahi mau maʻi ʻino, hiki i kāu kauka ke hoʻomaka iā ʻoe ma kahi lāʻau haʻahaʻa. A laila e hoʻoponopono lākou iā ia ma ka manawa e hiki i ke ana i kūpono iā ʻoe.

Hōʻike ka ʻikepili aʻe i nā lāʻau i hoʻohana pinepine ʻia a koi ʻia paha. Eia nō naʻe, e mālama pono i nā lāʻau a ke kauka i kuhikuhi ai nāu. E hoʻoholo kāu kauka i ke ana ʻoi loa e kūpono i kāu mau pono.

Nā ʻano lāʻau a me nā ikaika

Hele mai ʻo Gleevec ma ke ʻano he papaha āu e lawe ai ma ka waha (ale ʻoe iā ia). Loaʻa ia i nā papa 100-mg a me nā papa 400-mg.

Hiki mai nā ʻōmole 100-mg a me 400-mg i nā ʻōmole. Hele mai nā papa 400-mg i loko o nā ʻeke pelele i paʻakikī e wehe nā keiki.

Nā dosage Gleevec

ʻO nā mahele aʻe nā ʻano dosages hoʻomaka no kēlā me kēia kūlana:

  • nā mākua me Philadelphia-positive (Ph +) myeloid leukemia (CML) i ka wā mau (ka pae mua o ka maʻi). 400 mg / lā
  • nā mākua me Ph + CML i ka manawa pōkole a i ʻole pohā pahū (ʻo ka ʻelua a me ke kolu o nā pae o ka maʻi): 600 mg / lā
  • nā mākua me ka Ph + huʻi lymphocytic leukemia (ALL): 600 mg / lā
  • nā mākua me ka myelodysplastic / myeloproliferative maʻi: 400 mg / lā
  • nā mākua me ka mastocytosis ʻōnaehana kolohe: 100 mg a i ʻole 400 mg / lā
  • nā mākua me ka maʻi hypereosinophilic a me / a i ʻole leukemia eosinophilic mau. 100 mg / lā a 400 mg / lā paha
  • nā mākua me nā dermatofibrosarcoma protuberans: 800 mg / lā
  • nā mākua me nā ʻōpū stromal gastrointestinal (GIST): 400 mg / lā

Kauoha paha kāu kauka i kahi lāʻau ʻokoʻa nāu. E hoʻokumu lākou ia ma ke ʻano o ka maikaʻi o ka pane ʻana o kou kino i ka lāʻau, pehea ke koʻikoʻi o kāu hopena a, a me nā kumu ʻē aʻe. Inā he mau nīnau kāu e pili ana i ke ana pono o Gleevec nāu, e kamaʻilio me kāu kauka.

ʻĀpana pēpē

Nā hana no nā keiki eia kēia:

  • nā keiki me Ph + CML i ka wā mau (ka pae mua o ka maʻi). 340 mg / m2 / lā
  • keiki me Ph + ALL: 340 mg / m2 / lā e lawe ʻia me chemotherapy

E hoʻokumu ke kauka o kāu keiki i ka mahele lāʻau i ke kiʻekiʻe a me ke kaumaha o kāu keiki. (No laila 340 mg / m2 340 mg no ka mika mika o ka ʻili o ke kino.) Eia kekahi laʻana, inā he 4 kapuaʻi ke kiʻekiʻe o kāu keiki a kaupaona ʻia he 49 lbs. No laila ʻo ka hana no Ph + CML he 300 mg.

He aha inā e haʻo wau i kahi lāʻau?

Inā ʻoe e nalo i kahi mahele o Gleevec, e lawe i kahi ke hoʻomanaʻo ʻoe. Inā kokoke i ka manawa no kāu kaukona aʻe, kali a lawe i ka lāʻau aʻe e like me ka mea i hoʻonohonoho ʻia. Mai lawe i ʻelua mau kaha e pani no ka mahele lāʻau i hala. Hiki i kēia ke hoʻonui i kou makaʻu no nā hopena ʻaoʻao koʻikoʻi.

Pono wau e hoʻohana i kēia lāʻau lōʻihi?

Hoʻohana ʻia ʻo Gleevec ma ke ʻano he lapaʻau lōʻihi. Inā hoʻoholo ʻoe a me kāu kauka he palekana a maikaʻi ʻo Gleevec nāu, lawe paha ʻoe i kahi wā lōʻihi.

Nā koho ʻē aʻe iā Gleevec

Loaʻa nā lāʻau ʻē aʻe i hiki ke mālama i kou ʻano. Kūpono paha kekahi iā ʻoe ma mua o nā poʻe ʻē aʻe. Inā hoihoi ʻoe i ka ʻimi ʻana i kahi ʻē aʻe iā Gleevec, e kamaʻilio me kāu kauka e aʻo hou e pili ana i nā lāʻau ʻē aʻe e holo pono paha iā ʻoe.

Kaha: Hoʻohana ʻia kekahi o nā lāʻau i helu ʻia ma aneʻi i ka lepili e mālama ai i kēia mau ʻano kikoʻī.

Nā koho ʻē aʻe no CML

Nā laʻana o nā lāʻau ʻē aʻe i hiki ke hoʻohana ʻia e mālama iā Philadelphia-positive (Ph +) leukemia myeloid mau (CML) ʻo:

  • dasatinib (Sprycel)
  • nilotinib (Tasigna)
  • bosutinib (Bosulif)
  • ponatinib (Iclusig)
  • omacetaxine (Synribo)
  • daunorubicin (Cerubidine)
  • cytarabine
  • interferon-alpha (Intron A)

Nā koho ʻē aʻe no GIST

ʻO nā laʻana o nā lāʻau ʻē aʻe i hiki ke hoʻohana ʻia e mālama i nā tumomoma stromal gastrointestinal (GIST):

  • sunitinib (Sutent)
  • regorafenib (Stivarga)
  • sorafenib (Nexavar)
  • nilotinib (Tasigna)
  • dasatinib (Sprycel)
  • pazopanib (Votrient)

Loaʻa nā koho ʻē aʻe no nā kūlana ʻē aʻe Gleevec. E kamaʻilio me kāu kauka e pili ana i nā lāʻau i hiki ke hoʻohana ʻia no kāu maʻi.

ʻO Gleevec vs. Tasigna

Mahalo paha ʻoe pehea e hoʻohālikelike ai ʻo Gleevec i nā lāʻau ʻē aʻe i kuhikuhi ʻia no nā hoʻohana like. Maanei mākou e nānā ai i ka like a like ʻole o Gleevec a me Tasigna.

Hoʻohana

Ua ʻae ka Food and Drug Administration (FDA) iā Gleevec a me Tasigna e mālama i kekahi ʻano maʻi maʻi koko.

Ua ʻae ʻia nā lāʻau ʻelua e kauka e hoʻomaʻamaʻa hou ʻia ʻo Philadelphia-positive (Ph +) leukemia myeloid mau loa (CML) i ka manawa mau o nā mākua a me nā keiki.

Māhele ʻia ka leukemia myeloid maʻi (CML) i ʻekolu mau hanana:

  • Pae kau. ʻO kēia ka pae mua o CML. Hoʻomaopopo ʻia ka hapanui o ka poʻe me CML i ka wā hoʻomau. Mālie nā ʻōuli, inā aia kekahi.
  • ʻĀina wikiwiki. I kēia pae ʻelua, piʻi ka nui o nā hunaola maʻi ʻaʻai i loko o kou koko. Loaʻa paha iā ʻoe nā hōʻailona hou aku, e like me ke kuni a me ka pohō kaumaha.
  • ʻAha pōpilikia pahū. I kēia pae holomua loa, ua pālahalaha ʻia nā hunaola maʻi ʻaʻai i loko o kou koko i nā ʻōpala a me nā ʻaʻa ʻē aʻe. ʻOi aku paha ke koʻikoʻi o kāu mau hōʻailona.

Ua ʻae ʻia ʻo Gleevec e mālama iā Philadelphia-positive (Ph +) CML i nā mākua i ka wā mau, holo wikiwiki, a i ʻole wā pōkole inā ʻaʻole i holo ka interferon-alpha therapy.

ʻO Interferon-alpha kahi lāʻau i hoʻohana mau ʻia e mālama iā CML i ka wā i hala. He lāʻau hana ia na ke kanaka e hana e like me kekahi protein immune system a pale i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

Ua ʻae ʻia ʻo Tasigna e mālama iā Ph + CML i nā manawa hoʻomau a i hōʻeleu ʻia paha i nā mākua inā ʻaʻole i hana nā ʻano lapaʻau ʻē aʻe, e like me ka lapaʻau ʻana me Gleevec. ʻAʻole ʻae ʻia ʻo Tasigna no ka wā pilikia pahū.

Ua ʻae ʻia ʻo Tasigna e mālama iā Ph + CML i nā keiki mai 1 mau makahiki a ʻoi paha inā ʻaʻole i hana nā ʻano lāʻau ʻē aʻe. ʻAe ʻia ʻo Gleevec e mālama iā Ph + CML hou i hōʻike ʻia i nā keiki.

ʻAe ʻia ʻo Gleevec e mālama i nā ʻano ʻē aʻe. E ʻike i ka mahele “Nā hoʻohana ʻē aʻe no Gleevec” e aʻo hou ai.

Nā ʻano lāʻau a me ka hoʻoponopono ʻana

Loaʻa i ka Gleevec ka imatinib lāʻau. Aia i loko o Tasigna ka lāʻau nilotinib.

Hele mai ʻo Gleevec ma ke ʻano he papa. Hele mai ʻo Tasigna ma ke ʻano he capsule. Lawe ʻia nā lāʻau ʻelua e ka waha.

Lawe ʻia ʻo Gleevec hoʻokahi a ʻelua mau manawa paha i ka lā, ke kaukaʻi ʻia i kāu lāʻau. Lawe ʻia ʻo Tasigna i ʻelua mau manawa i ka lā.

Hele mai ʻo Gleevec ma ke ʻano he 100-mg a me 400-mg mau papa. Hele mai ʻo Tasigna ma ke ʻano he 50-mg, 150-mg, a me 200-mg capsule.

Nā hopena a me nā pilikia

Loaʻa iā Gleevec a me Tasigna nā lāʻau like. No laila, hiki i nā lāʻau ʻelua ke hana i nā hopena ʻaoʻao like loa. Ma lalo nā hiʻohiʻona o kēia mau hopena ʻaoʻao.

Nā hopena ʻaoʻao hou aʻe

Aia i loko o kēia mau papa inoa nā laʻana o nā hopena ʻē aʻe i hiki ke hana ʻia me Gleevec, me Tasigna, a i ʻole me nā lāʻau ʻelua (ke lawe pākahi ʻia).

  • Hiki ke hana me Gleevec:
    • edema (ʻōhū o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae, a puni kou mau maka)
    • ʻūpē mākala
    • ʻeha ʻeha
    • ʻeha iwi
    • ʻeha ka ʻōpū
  • Hiki ke hana me Tasigna:
    • ʻeha poʻo
    • ʻili ʻili
    • ʻūhā
    • kōpaʻa
    • ʻeha pū
    • nasopharyngitis (maʻamau anu)
    • fiva
    • puhū pō
  • Hiki ke hana me nā Gleevec a me Tasigna:
    • nausea
    • ka luaʻi
    • pāhoehoe
    • hūwī
    • luhi (nele o ka ikaika)

Nā hopena hopena koʻikoʻi

Aia i loko o kēia mau papa inoa nā laʻana o nā hopena ʻino e hiki ke hana me Gleevec, me Tasigna, a i ʻole me nā lāʻau ʻelua (ke lawe pākahi ʻia).

  • Hiki ke hana me Gleevec:
    • kūleʻa puʻuwai congestive a i ʻole nā ​​pilikia puʻuwai e like me ka maikaʻi ʻole o ka puʻuwai hema
    • gastrointestinal perforations (puka i loko o kou ʻōpū a me kou ʻōpū)
    • nā hopena ʻili koʻikoʻi, e like me ka maʻi maʻi ʻo Stevens-Johnson (fiva; ʻehaʻeha ma kou waha, ʻāʻī, maka, genitalia, a i ʻole ke kino holoʻokoʻa)
    • hōʻino kīhāpai
    • hypothyroidism (pae haʻahaʻa thyroid) i ka poʻe i hemo kā lākou thyroid
  • Hiki ke hana me Tasigna:
    • wā lōʻihi QT (ka hana uila uila i loko o kou puʻuwai), he mea laha ʻole akā hiki ke hopena i ka make koke
    • ālai ʻia nā kīʻaha koko i ka puʻuwai
    • pancreatitis
    • electrbalte imbalances (kiʻekiʻe a i ʻole pae haʻahaʻa o kekahi mau minelala)
  • Hiki ke hana me nā Gleevec a me Tasigna:
    • nā maʻi koko, me ka anemia (nā pae haʻahaʻa o nā hunaola ʻulaʻula), neutropenia (nā pae haʻahaʻa o nā hunaola keokeo), a me ka thrombositopenia (nā pae haʻahaʻa o nā platelet)
    • hōʻino ka ate
    • tumo lysis maʻi pale (maʻi koʻohune ke kala i nā Nine Inch weliweli i loko o kou koko)
    • hemorrhage (kahe ʻole ke koko)
    • paʻa kahe paʻa (ʻoi loa ka wai a wai paha)
    • lohi ka ulu ʻana o nā keiki

Ka hoʻokō ʻana

Loaʻa iā Gleevec a me Tasigna nā ʻano ʻokoʻa i ʻae ʻia e ka FDA. Akā mālama lāua ʻelua iā Ph + CML i nā manawa hoʻomau a me ka wikiwiki inā ʻaʻole i holo kekahi mau ʻano lāʻau ʻē aʻe. ʻEkolu mau ʻāpana o ka CML: ka lōʻihi (pae 1), ka wikiwiki (pae 2), a me ka ulia pōpilikia (pae 3).

Hoʻohālikelike ka hoʻohana ʻana o Gleevec a me Tasigna i ka mālama ʻana iā Ph + CML hou i nā mākua i kahi noiʻi hoʻokolohua. Hoʻohālikelike nā kānaka noiʻi i ka poʻe i lawe i 400 mg o Gleevec i hoʻokahi manawa i ka lā a i ʻole 300 mg o Tasigna i ʻelua mau lā i ka lā.

Ma hope o 12 mau mahina o ka mālama ʻana, 65% o ka poʻe i lawe iā Gleevec ʻaʻohe o lākou mau hunaola Ph + i ko lākou iwi iwi (kahi e ulu ai nā hunaola CML maʻi ʻaʻai). ʻO nā poʻe i lawe iā Tasigna, 80% ʻaʻohe o lākou mau Ph + cell i ko lākou iwi iwi.

Ma hope o ʻelima mau makahiki o ka mālama ʻana, 60% o ka poʻe i lawe iā Gleevec ua hōʻemi loa i nā helu maʻi ʻaʻai i loko o kā lākou koko. Ua hoʻohālikelike ʻia kēia me 77% o ka poʻe i lawe iā Tasigna.

Ma hope o ʻelima mau makahiki o ka mālama ʻana, 91.7% o ka poʻe i lawe iā Gleevec e ola nei. Hoʻohālikelike ʻia me 93.7% o ka poʻe i lawe iā Tasigna.

Hōʻike nā hopena o kēia noi ʻana e ʻoi aku ka maikaʻi o Tasigna ma mua o Gleevec i ka mālama ʻana iā Ph + CML hou i ka wā maʻi.

Nā kumukūʻai

ʻO Gleevec lāua ʻo Tasigna nā lāʻau lapaʻau inoa ʻelua. ʻAʻohe o generic form ʻo Tasigna, akā he ʻano generic kā Gleevec i kapa ʻia imatinib. ʻOi aku ke kumu kūʻai o nā lāʻau lapaʻau inoa inoa ma mua o nā generics.

Wahi a nā koho ma GoodRx.com, ʻoi aku ka uku o ka inoa inoa Gleevec ma mua o Tasigna. ʻO ke ʻano generic o Gleevec (imatinib) he kumukūʻai hoʻi ma mua o Tasigna. ʻO ke kumukūʻai maoli āu e uku ai no nā lāʻau ʻelua e pili ana i kāu lāʻau, hoʻolālā inikua, kou wahi, a me ka lāʻau kūʻai āu e hoʻohana ai.

Gleevec vs. Sprycel

Mahalo paha ʻoe pehea e hoʻohālikelike ai ʻo Gleevec i nā lāʻau ʻē aʻe i kuhikuhi ʻia no nā hoʻohana like. Maanei mākou e nānā ai pehea e like ai a ʻokoʻa ai ʻo Gleevec a me Sprycel.

Hoʻohana

Ua ʻae ka Food and Drug Administration (FDA) iā Gleevec a me Sprycel e mālama i kekahi ʻano maʻi maʻi koko.

Ua ʻae ʻia nā lāʻau ʻelua i ka FDA e mālama i kahi mea hou i hōʻike ʻia ʻo Philadelphia-positive (Ph +) leukemia myeloid mau loa (CML) i ka manawa mau o nā mākua a me nā keiki.

Māhele ʻia ʻo CML i ʻekolu mau hanana:

  • Pae kau. ʻO kēia ka pae mua o CML. Hoʻomaopopo ʻia ka hapanui o ka poʻe me CML i ka wā hoʻomau. Mālie nā ʻōuli, inā aia kekahi.
  • ʻĀina wikiwiki. I kēia pae ʻelua, piʻi ka nui o nā hunaola maʻi ʻaʻai i loko o kou koko. Loaʻa paha iā ʻoe nā hōʻailona hou aku, e like me ke kuni a me ka pohō kaumaha.
  • ʻAha pōpilikia pahū. I kēia pae holomua loa, ua pālahalaha ʻia nā hunaola maʻi ʻaʻai i loko o kou koko i nā ʻōpala a me nā ʻaʻa ʻē aʻe. ʻOi aku paha ke koʻikoʻi o kāu mau hōʻailona.

Hoʻohana ʻia ʻo Gleevec a me Sprycel e mālama iā Ph + CML i nā mākua i ka wā mau.

Hoʻohana ʻia ʻo Gleevec e mālama iā Ph + CML i nā mākua i nā manawa mau, wikiwiki, a me nā pōpilikia inā ʻaʻole i holo ka interferon-alpha therapy. ʻO Interferon-alpha kahi lāʻau i hoʻohana mau ʻia e mālama iā CML i ka wā i hala. He lāʻau hana ia na ke kanaka e hana e like me kekahi protein immune system a pale i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

Hoʻohana ʻia ʻo Sprycel e mālama iā Ph + CML i nā mākua i nā manawa mau, wikiwiki, a me nā pōpilikia inā ʻaʻole i holo ʻo Gleevec.

Ua ʻae ʻia ʻo Gleevec a me Sprycel e mālama iā Ph + CML i ka manawa mau o nā keiki. Ua ʻae ʻia lāua ʻelua e mālama iā Ph + huakō lymphocytic leukemia (ALL) i nā keiki me chemotherapy.

ʻAe ʻia ʻo Gleevec e mālama i nā ʻano ʻē aʻe. E ʻike i ka mahele “Nā hoʻohana ʻē aʻe no Gleevec” e aʻo hou ai.

Nā ʻano lāʻau a me ka hoʻoponopono ʻana

Loaʻa i ka Gleevec ka imatinib lāʻau. Loaʻa i ka Sprycel ka lāʻau dasatinib.

Hele mai ʻo Gleevec lāua ʻo Sprycel ma ke ʻano he mau papa e lawe ai ʻoe ma ka waha (ale ʻoe iā lākou).

Hele mai nā papa Gleevec i nā ikaika ʻelua: 100 mg a 400 mg. Lawe ʻia hoʻokahi a ʻelua mau manawa paha i ka lā, ke kaukaʻi ʻia i kāu lāʻau.

Hele mai nā papa Sprycel i nā ikaika e hiki mai ana: 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, a me 140 mg. Lawe ʻia ʻo Sprycel i hoʻokahi manawa i ka lā.

Nā hopena a me nā pilikia

Kūlike ʻo Gleevec a me Sprycel akā loaʻa nā lāʻau ʻokoʻa. No laila, hiki i nā lāʻau ʻelua ke hana i nā hopena ʻaoʻao like loa. Ma lalo nā hiʻohiʻona o kēia mau hopena ʻaoʻao.

Nā hopena ʻaoʻao hou aʻe

Aia i loko o kēia mau papa inoa nā laʻana o nā hopena ʻē aʻe i hiki ke hana ʻia me Gleevec, me Sprycel, a i ʻole me nā lāʻau ʻelua (ke lawe pākahi ʻia).

  • Hiki ke hana me Gleevec:
    • ka luaʻi
    • ʻūpē mākala
    • ʻeha ka ʻōpū
    • edema maka-ʻā (ʻōhū a puni nā maka)
  • Hiki ke hana me Sprycel:
    • pilikia hanu
    • ʻeha poʻo
    • kahe ana ke koko
    • hoʻonāwaliwali ʻōnaehana pale (ʻaʻole hiki i kou kino ke hakakā i nā maʻi pū kekahi)
  • Hiki ke hana me Gleevec a me Sprycel:
    • edema (hāhā o kou mau wāwae, nā kuʻekuʻe wāwae, a me nā wāwae)
    • nausea
    • ʻeha ʻeha
    • ʻeha iwi
    • pāhoehoe
    • hūwī
    • luhi (nele o ka ikaika)

Nā hopena hopena koʻikoʻi

Aia i loko o kēia mau papa inoa nā laʻana o nā hopena ʻino e hiki ke hana me Gleevec, me Sprycel, a i ʻole me nā lāʻau ʻelua (ke lawe pākahi ʻia).

  • Hiki ke hana me Gleevec:
    • nā pilikia puʻuwai, e like me ka puʻuwai puʻuwai congestive
    • hōʻino ka ate
    • gastrointestinal perforations (puka i loko o kou ʻōpū a me kou ʻōpū)
    • hōʻino kīhāpai
    • hypothyroidism (pae haʻahaʻa thyroid) i ka poʻe i hemo kā lākou thyroid
  • Hiki ke hana me Sprycel:
    • pulmonary arterial hypertension (ke koko kiʻekiʻe i nā kīʻaha koko i kou mau māmā)
    • ka wā QT lōʻihi (kahi ʻano o ka hana uila uila ʻole i loko o kou puʻuwai)
    • hoʻouka puʻuwai ischemic (nele o ka oxygen i nā mākala puʻuwai)
  • Hiki ke hana me Gleevec a me Sprycel:
    • paʻa kahe nui (ka nui o ka wai a wai paha) a puni kou mau māmā, puʻuwai, a me kou ʻōpū
    • nā maʻi koko koʻikoʻi (nā pae haʻahaʻa o nā hunaola ʻulaʻula, platelet, a i ʻole nā ​​ʻula koko keʻokeʻo)
    • hemorrhage nui (kahe ʻole ke koko)
    • nā hopena ʻili koʻikoʻi, e like me ka maʻi maʻi ʻo Stevens-Johnson (fiva; ʻehaʻeha ma kou waha, ʻāʻī, maka, genitalia, a i ʻole ke kino holoʻokoʻa)
    • tumo lysis maʻi pale (maʻi koʻohune ke kala i nā Nine Inch weliweli i loko o kou koko)
    • ka helu o ka puʻuwai a i ʻole ka ritim (kuʻi ka puʻuwai i wikiwiki loa, lohi, a i ʻole kaulike)
    • ulu ulu o nā keiki

Ka hoʻokō ʻana

ʻO Gleevec lāua ʻo Sprycel he mau hoʻohana ʻokoʻa i ʻae ʻia e ka FDA. Akā mālama lāua ʻelua i ka Ph + CML hou ʻia i ka pae mau (ka pae mua o CML) i nā mākua a me nā keiki. Mālama pū ʻo Gleevec lāua ʻo Sprycel iā Ph + ALL i nā keiki ke hoʻohana ʻia me ka chemotherapy.

Hoʻohui ʻia, mālama ʻo Gleevec lāua ʻo Sprycel iā Ph + CML i nā pae holomua a hāhā i nā mākua, a i ʻole Ph + ALL, inā ʻaʻole i holo pono nā lāʻau ʻē aʻe na lāua.

Hoʻohālikelike ʻia ka hoʻohana ʻana o Gleevec a me Sprycel i ka mālama ʻana iā Ph + CML hou i ka poʻe mākua i kahi noiʻi hoʻokolohua. Hoʻohālikelike nā kānaka noiʻi i ka poʻe i lawe i 400 mg o Gleevec i kahi lā a i ʻole 100 mg o Sprycel i ka lā.

Ma waena o 12 mau mahina, 66.2% o ka poʻe i lawe iā Gleevec ʻaʻohe o lākou mau huna Ph + i ko lākou iwi iwi (kahi e ulu ai nā hunaola CML maʻi ʻaʻai). I ka hui i lawe iā Sprycel, 76.8% o ka poʻe ʻaʻohe o lākou keena Ph + i ko lākou iwi iwi.

Ma hope o ʻelima mau makahiki o ka mālama ʻana, ua ola he 89.6% o ka poʻe i lawe iā Gleevec. Hoʻohālikelike ʻia i kahi 90.9% i koho ʻia o ka poʻe i lawe iā Sprycel.

Hōʻike nā hopena o kēia hoʻopaʻa ʻana e ʻoi aku paha ka maikaʻi o Sprycel ma mua o Gleevec i ka mālama ʻana iā Ph + CML hou i ka wā mau.

Nā kumukūʻai

ʻO Gleevec lāua ʻo Sprycel nā lāʻau lapaʻau inoa ʻelua. ʻAʻohe o generic form a Sprycel, akā he ʻano generic kā Gleevec i kapa ʻia imatinib. ʻOi aku ke kumu kūʻai o nā lāʻau lapaʻau inoa inoa ma mua o nā generics.

Wahi a nā koho ma GoodRx.com, ʻoi aku ka uku o ka inoa inoa Gleevec ma mua o Sprycel. ʻO ke ʻano generic o Gleevec (imatinib) kahi mea kūʻai aku paha ma mua o Sprycel. ʻO ke kumukūʻai maoli āu e uku ai no nā lāʻau ʻelua e pili ana i kāu lāʻau, kāu hoʻolālā ʻinikua, kou wahi, a me ka hale kūʻai āu e hoʻohana ai.

Gleevec a me ka waiʻona

ʻAʻole maopopo inā pili paha ʻo Gleevec a me ka waiʻona i kekahi.

Eia nō naʻe, metabolises (haki i kou ake) nā Gleevec a me nā waiʻona. No laila ke inu nei i ka waiʻona nui ke lawe nei ʻoe iā Gleevec e pale paha i kou ake mai ka wāwahi ʻana i ka lāʻau. Hiki i kēia ke hāpai i nā kiʻekiʻe o Gleevec i kou kino a hoʻonui i kou makaʻu no nā hopena ʻino, a me nā hōʻino o ke ake.

Hiki i nā Gleevec a me ka waiʻona ke hana i nā hopena ʻē aʻe e like me:

  • nausea
  • pāhoehoe
  • ʻeha poʻo
  • luhi (nele o ka ikaika)

ʻO ka inu ʻana i ka waiʻona i kou wā Gleevec lapaʻau hiki ke hoʻonui i kou makaʻu i ka loaʻa ʻana o kēia mau hopena ʻaoʻao.

Inā inu ʻoe i ka waiʻona, e kamaʻilio me kāu kauka e pili ana i ka nui o ka palekana iā ʻoe i kāu wā Gleevec.

Nā pilina Gleevec

Hiki iā Gleevec ke launa pū me nā lāʻau ʻē aʻe. Hiki iā ia ke launa pū me kekahi mau mea hoʻopihapiha a me kekahi mau meaʻai.

Hiki i nā launa like ʻole ke kumu i nā hopena like ʻole. ʻO kahi laʻana, hiki i kekahi ke hoʻopilikia i ka maikaʻi o ka hana ʻana o ka lāʻau, ʻoiai ʻo kekahi e hoʻonui i nā hopena ʻaoʻao.

Gleevec a me nā lāʻau ʻē aʻe

Ma lalo ka papa inoa o nā lāʻau i hiki ke launa pū me Gleevec. ʻAʻohe i loko o kēia papa inoa nā lāʻau āpau e launa pū me Gleevec.

Ma mua o ka lawe ʻana iā Gleevec, e kamaʻilio me kāu kauka a me kāu kauka lāʻau. E haʻi iā lākou e pili ana i nā kuhikuhi āpau, nā mea kūʻai aku, a me nā lāʻau ʻē aʻe āu e lawe ai. E haʻi pū iā lākou e pili ana i nā wikamina, nā mea kanu, a me nā mea hoʻopiha āu e hoʻohana ai. Hiki ke kōkua i ka hāʻawi ʻana i kēia ʻike iā ʻoe e hōʻalo i nā launa ʻole.

Inā he mau nīnau kāu e pili ana i nā launa lāʻau e hoʻopili iā ʻoe, e nīnau i kāu kauka a kauka paha.

ʻO Gleevec lāua ʻo Tylenol

Lawe iā Gleevec me Tylenol (acetaminophen) hiki ke hoʻonui i kou makaʻu no nā hopena ʻino, e like me ka hōʻino o ke ake.

ʻO nā Enzymes (nā protein kūikawā) i kou ake e wāwahi i nā Gleevec a me Tylenol. Hiki pū, hiki i nā lāʻau ʻelua ke hoʻokahuli i nā enzyme a hōʻino i nā hunaola i kou ake.

E nīnau i kāu kauka inā palekana iā ʻoe e lawe iā Tylenol i ka wā o kāu mālama iā Gleevec.

Gleevec a me kekahi mau lāʻau hopu

Lawe iā Gleevec me kekahi mau lāʻau i hopu ʻia hiki ke hoʻēmi i nā pae Gleevec i kou kino. Hiki i kēia ke hana iā Gleevec i mea liʻiliʻi (hana maikaʻi ʻole).

ʻO nā laʻana o nā lāʻau i hopu ʻia e hiki ke hoʻemi i nā pae Gleevec e komo pū ana:

  • phenytoin (Dilantin, Phenytek)
  • carbamazepine (Carbatrol, Tegretol)
  • phenobarbital

Inā ʻoe e lawe iā Gleevec a me kekahi mau lāʻau hopu, hiki i kāu kauka ke kuhikuhi i kahi lāʻau ʻālau ʻokoʻa a i ʻole hoʻoponopono i ke ana o Gleevec.

Gleevec a me kekahi mau antibiotic

Lawe iā Gleevec me kekahi mau lāʻau antibiotic (nā lāʻau e mālama i nā maʻi bacteria) hiki ke hoʻonui i nā pae Gleevec i kou kino. Pale aku nā Antibiotics iā Gleevec mai ka haki ʻana i kou kino. Hoʻonui kēia i kou makaʻi no nā hopena ʻaoʻao koʻikoʻi.

ʻO kahi laʻana o kahi antibiotic i hiki ke hoʻonui i nā pae Gleevec ʻo clarithromycin (Biaxin XL).

Inā lawe ʻoe iā Gleevec a makemake i kahi antibiotic, hiki i kāu kauka ke nānā iā ʻoe no nā hopena ʻaoʻao. Hiki iā lākou ke hōʻemi i kāu hana Gleevec no kekahi manawa.

Gleevec a me kekahi mau antifungals

Lawe iā Gleevec me kekahi mau antifungals (nā lāʻau e mālama i nā maʻi fungal) hiki ke pale i ka haki o Gleevec i kou kino. Hiki i kēia ke hāpai i nā pae Gleevec i loko o kou koko a hoʻonui i kou makaʻi no nā hopena ʻino.

Nā laʻana o nā antifungals i hiki ke hoʻonui i nā pae Gleevec:

  • itraconazole (Onmel, Sporanox, Tolsura)
  • ketoconazole (Extina, Ketozole, Xolegel)
  • voriconazole (Vfend)

Inā ʻoe e lawe iā Gleevec a pono i ka lāʻau antifungal, e nānā ke kauka iā ʻoe no nā hopena ʻaoʻao. Hiki iā lākou ke hōʻemi i kāu hana Gleevec no kekahi manawa.

Gleevec a me nā opioids

Lawe iā Gleevec me kekahi mau lāʻau lapaʻau ʻeha e hiki ke hoʻonui i nā pae o ka mea hōʻoluʻolu ʻeha i kou kino. ʻO kēia ka mea e loaʻa iā ʻoe i nā hopena ʻē aʻe e like me ka sedation (hiamoe a emi iki ka makaʻala) a me ke kaumaha o ka hanu (hanu mālie).

ʻO nā laʻana o nā lāʻau ʻeha opioid i hiki ke hoʻonui i nā pae Gleevec me:

  • ʻoxycodone (Oxycontin, Roxicodone, Xtampza ER)
  • tramadol (ConZip, Ultram)
  • methadone (Dolophine, Methadose)

E kamaʻilio me kāu kauka e pili ana inā palekana ka lawe ʻana i nā lāʻau ʻeha i ka wā o kāu mālama iā Gleevec. Hōʻike paha lākou i nā ala ʻē aʻe e hōʻoluʻolu ai i kou ʻeha.

Gleevec a me kekahi mau lāʻau HIV

Lawe iā Gleevec me kekahi mau lāʻau lapaʻau HIV hiki ke hoʻonui i kou makaʻu no nā hopena ʻino. Hiki i kekahi mau lāʻau HIV ke pale aku iā Gleevec mai ka wāwahi ʻana, e alakaʻi ana i nā kiʻekiʻe kiʻekiʻe o Gleevec i kou kino.

Nā laʻana o nā lāʻau lapaʻau HIV e hiki ai ke hoʻonui i nā pae Gleevec i loko:

  • atazanavir (Reyataz)
  • nevirapine (Viramune)
  • saquinavir (Hoʻokele)

ʻO kekahi lāʻau HIV, efavirenz (Sustiva), hiki ke hoʻemi i nā kiʻekiʻe o Gleevec i kou kino. Hiki i kēia ke kumu o ka maikaʻi o ka Gleevec.

Hele mai nā lāʻau lapaʻau he nui i nā papa hoʻohui, ʻo ia hoʻi hoʻokomo lākou ma mua o hoʻokahi lāʻau. No laila e kamaʻilio pū me kāu kauka e pili ana i nā lāʻau HIV āpau āu e lawe ai.

Inā pono ʻoe e lawe iā Gleevec me kekahi mau lāʻau HIV, hiki i kāu kauka ke hoʻololi i kāu hana Gleevec.

ʻO Gleevec a me kekahi mau lāʻau kahe koko

Lawe iā Gleevec me kekahi mau lāʻau kaomi koko hiki ke hoʻonui a hōʻemi paha i nā kiʻekiʻe o nā lāʻau i loko o kou kino. Hiki iā ʻoe ke loaʻa i nā ʻaoʻao a hōʻemi paha i ka maikaʻi o ka hana ʻana o nā lāʻau.

ʻO kahi laʻana o kēia mau lāʻau e pili ana iā verapamil (Calan, Tarka).

Inā pono ʻoe e lawe iā Gleevec me kekahi o kēia mau lāʻau, e nānā pono kāu kauka iā ʻoe no nā hopena ʻaoʻao. Hoʻololi paha lākou i ke ana o nā lāʻau a koi paha i kahi lāʻau ʻokoʻa.

ʻO Gleevec a me warfarin

Lawe iā Gleevec me warfarin (Coumadin, Jantoven) hiki ke hoʻonui i kou makaʻu no ke kahe ʻana o ke kahe. Pale ʻo Gleevec i ka warfarin mai ka wāwahi ʻana i kou kino. Hoʻonui kēia i nā pae o warfarin a hiki ke alakaʻi i ke kahe e paʻakikī e kaohi.

Inā makemake ʻoe i kahi anticoagulant (wīwī o ke koko) ʻoiai ke lawe nei iā Gleevec, e kuhikuhi paha kāu kauka i kahi lāʻau ʻē aʻe ma mua o warfarin.

ʻO Gleevec lāua ʻo St.

Lawe iā Gleevec me ka wort o St. John hiki ke hoʻemi i nā kiʻekiʻe o Gleevec i kou kino. Hiki i kēia ke hoʻolilo iā Gleevec i mea liʻiliʻi (ʻaʻole pono e hana).

E noi i kāu kauka inā palekana ʻo Wort John wort nāu e lawe i ka wā o kāu mālama Gleevec. Hiki paha iā lākou ke ʻōlelo i kahi koho ʻē aʻe i St. John's Wort a hoʻonui paha i kāu lāʻau Gleevec.

ʻO Gleevec a me ka hua waina

ʻO ka ʻai ʻana i ka huaʻulu a me ka inu ʻana i ka wai momona i ka wā o kāu hoʻoponopono Gleevec hiki ke hoʻonui i kou makaʻu no nā hopena ʻino. Loaʻa ka huaola i ka huaola i pale i ka haʻihaʻi ʻia o Gleevec i kou kino. ʻO kēia ke kumu o ka hoʻonui ʻia o nā kiʻekiʻe o Gleevec, i hiki ke alakaʻi i nā hopena ʻē aʻe i ʻoi loa.

E hōʻalo pono i ka ʻai ʻana i ka huaʻulu a me ka inu ʻana i ka wai huaʻakeʻake i kou wā Gleevec.

Pehea e lawe ai iā Gleevec

E mālama pono iā Gleevec e like me kāu kauka a i ʻole nā ​​ʻōkuhi mālama ola.

I ka manawa hea e lawe ai

No nā kaha Gleevec o 600 mg a ʻoi aku paha, pono e lawe i ka lāʻau i hoʻokahi manawa i ka lā. Hiki iā ʻoe ke lawe ia i kēlā me kēia manawa.

Inā kau kauka i 800 mg o Gleevec i ka lā, lawe ʻoe iā ia i ʻelua mau kaha: 400 mg i ke kakahiaka a me 400 mg i ke ahiahi.

E hāʻawi aku kāu kauka iā ʻoe i nā ʻōkuhi ke lawe ʻoe i kāu lāʻau.

Lawe iā Gleevec me ka meaʻai

E lawe iā Gleevec me kahi pāʻina a me kahi aniani wai nui. Hiki i kēia ke pale i ka ʻōpū huhū.

Hiki iā Gleevec ke haki, wāwahi ʻia, a nau ʻia paha.

ʻAʻole pono ʻoe e wāwahi, wāwahi, a nau i nā papa Gleevec. Hiki i nā papa ʻoki a hoʻokaʻawale ke hōʻeha i kekahi ʻili a i ʻole nā ​​ʻāpana kino ʻē aʻe i pili pū me lākou.

Inā pilikia ʻoe i ka ale ʻana i nā papa Gleevec, kau i ka papa i loko o ke kīʻaha wai nui a i ʻole ka wai ʻāpala. E hoʻoulu i ka wai me kahi puna e kōkua ai i ka papa e hoʻoheheʻe. A laila inu koke i ka hui.

Pehea e hana ai ʻo Gleevec

Loaʻa ʻo Gleevec i ka lāʻau imatinib, i pili i ka papa o nā lāʻau i kapa ʻia he tyrosine kinase inhibitors (TKI). Hoʻohālikelike nā lāʻau i ka papa hana lāʻau TKI. Hoʻopili lākou i nā protein kikoʻī loa i nā hunaola maʻi ʻaʻai.

ʻAe ʻia ʻo Gleevec e mālama i nā ʻano ʻano like ʻole. Ma aneʻi mākou e ʻimi ai i ka hana a Gleevec e mālama ai i ʻelua o lākou.

No Ph + CML

Ma Philadelphia-maikaʻi (Ph +) leukemia myeloid mau (CML), he hewa nā kele e hana i nā hunaola keokeo i kā lākou hanauna kūlohelohe. ʻIke ʻia kēia kuhi hewa ma kahi pae DNA i kapa ʻia ʻo chromosome Philadelphia.

Aia i loko o ka chromosome Philadelphia kahi ʻāpana ʻokoʻa (BCR-ABL1) i kumu e hoʻokumu ʻia nā hunaola keokeo he nui. ʻAʻole oʻo kēia mau keʻokeʻo koko a oʻo a make e like me kā lākou e manaʻo ai. ʻO nā hunaola keʻokeʻo ʻole i kapa ʻia ʻo "blasts" e hōʻuluʻulu i nā ʻano ʻē aʻe o ke koko e pono e hana pono kāu koko.

Hana ʻo Gleevec i ka hoʻopili ʻana i kahi protein, i kapa ʻia ʻo tyrosine kinase, i loko o nā pūnaewele i hana ʻia e BCR-ABL1. Ke hoʻopaʻa ʻo Gleevec i kēia protein, pale ka lāʻau i ke kele mai ka hoʻouna ʻana i nā hōʻailona e haʻi i ka ulu o ka cell. Me ka ʻole o kēia mau hōʻailona ulu, make nā aʻa koko maʻi maʻi. Kōkua kēia i ka hoʻihoʻi hou ʻana i ka helu o nā huna huna i kahi helu olakino.

No GIST

Kōkua pū ʻo Gleevec i ka mālama ʻana i nā ʻōpū stromal gastrointestinal (GIST). I loko o nā pūnaewele tuma GIST he nui aʻe o kekahi mau protein, i kapa ʻia ʻo Kit a me nā mea ulu i loaʻa i ka platelet (PDGF), ma mua o nā hunaola maʻamau. Kōkua kēia mau proteins i nā hunaola maʻi ʻaʻai e ulu a hoʻokaʻawale.

Kuhi ʻo Gleevec i kēia mau protein a pale iā lākou mai ka hana ʻana. Hoʻohiohi kēia i ka ulu ʻana o ka maʻi ʻaʻai. ʻO ia pū kekahi e make ai nā hunaola maʻi ʻaʻai.

Pehea ka lōʻihi o ka hana?

Pili ia. ʻO ka manawa ke hoʻomaka ʻo Gleevec e hana i ʻokoʻa no kēlā me kēia kanaka.

Nānā nā noiʻi maʻi i ka poʻe me CML i lawe iā Gleevec. I hoʻokahi mahina, ua hoʻemi ʻia ka helu o nā hunaola maʻi ʻaʻai i loko o ke koko ma kahi o ka hapalua o ka poʻe i ka wā o ka pilikia pahū (pae kiʻekiʻe o CML). I ke aʻo ʻana o ka poʻe me GIST nāna i lawe ʻo Gleevec, kū nā tumors i ka ulu ʻana a i ʻole emi iho i loko o ʻekolu mau mahina.

E nānā mau kāu kauka i kou koko e ʻike inā e hana ana ʻo Gleevec iā ʻoe.

Gleevec a hāpai

Pono ʻoe e hōʻalo iā Gleevec inā hāpai ʻoe. Ua hōʻike ʻia no ka hānau ʻole ʻana a me ka hōʻeha ʻana i ka ʻōpū i nā wahine i lawe iā Gleevec i ka wā hāpai. A i loko o nā noiʻi holoholona, ​​nā wahine hāpai hāpai i hāʻawi ʻia iā Gleevec i ka nui o ka makaʻu no ka hānau hānau.

Inā hāpai ʻoe, hiki i kāu kauka ke aʻoaʻo iā ʻoe e kali a hiki i ka manawa o kou hānau ʻana e hoʻomaka i ka lawe ʻana iā Gleevec. A i ʻole e ʻōlelo lākou i kahi lāʻau ʻokoʻa.

Inā lawe ʻoe iā Gleevec, he mea nui e hoʻohana i ka kaohi hānau kūpono i ʻole ʻoe e hāpai. Ma hope o kou lawe ʻana i kāu lā hope loa o Gleevec, e hoʻomau i ka hoʻohana ʻana i ka kaohi hānau no 14 mau lā.

Gleevec a me ka waiū hānai

Hōʻike nā noiʻi e hele ʻo Gleevec i ka waiū umauma kanaka. Hiki i kēia ke kumu i ka hōʻeha koʻikoʻi i kahi pēpē pēpē.

Inā hānai ʻoe a noʻonoʻo i ka lawe ʻana iā Gleevec, hiki i kāu kauka ke ʻōlelo iā ʻoe e haʻalele i ka hānai ʻana iā ʻoe ke hoʻomaka i ka lāʻau.

Ma hope o kou lawe ʻana i kāu lā hope loa o Gleevec, e kali ma ka liʻiliʻi o hoʻokahi mahina ma mua o kou hoʻomaka ʻana i ka hānai ʻana.

ʻO overlee dosis o Gleevec

Lawe i ka nui loa o ka Gleevec hiki ke hoʻonui i kou makaʻi no nā hopena ʻino.

Nā hōʻailona overdose

Hiki i nā ʻōuli o ka overdose ke komo pū me:

  • nausea
  • ka luaʻi
  • pāhoehoe
  • ʻeha ka ʻōpū
  • ʻāwīwī koʻikoʻi
  • Muscle spasms (twitches)
  • ʻeha poʻo
  • nele i ka makemake ʻole
  • nāwaliwali o nā mākala
  • luhi (nele o ka ikaika)
  • pehu
  • nā maʻi o ke koko, e like me nā pae haʻahaʻa o nā platelet, nā ʻulaʻula o ke koko, a i ʻole nā ​​aʻa koko keʻokeʻo
  • fiva

He aha e hana ai inā he overdose

Inā manaʻo ʻoe ua lawe nui ʻoe i kēia lāʻau, e kāhea i kāu kauka. Hiki iā ʻoe ke kāhea i ka ʻAmelika Hui Pū ʻIa o nā Poison Control ma 800-222-1222 a i ʻole hoʻohana i kā lākou mea hana pūnaewele. Akā inā koʻikoʻi kāu mau ʻōuli, e kāhea iā 911 a i ʻole e hele koke i kahi lumi pilikia kokoke.

Nā nīnau e pili ana iā Gleevec

Eia nā pane i kekahi o nā nīnau e nīnau pinepine ʻia e pili ana iā Gleevec.

ʻO Gleevec kahi ʻano chemotherapy?

ʻAʻole ʻenehana ʻo Gleevec kahi ʻano chemotherapy. ʻO Gleevec kahi lāʻau i hoʻomākaukau ʻia e hoʻopili i nā mole kikoʻī i nā hunaola maʻi ʻaʻai.

Ma ke koho ʻana i nā mole kikoʻī, nā therapies i hoʻolālā ʻia e like me Gleevec kōkua i ka hoʻolohi i ka ulu a hoʻolaha ʻana o nā hunaola maʻi ʻaʻai. E kauoha maʻamau kāu kauka i kahi lāʻau hoʻomākaukau ʻia no ʻoe e pili ana i ke ʻano o ka maʻi ʻaʻai āu.

ʻOkoʻa nā lāʻau Chemotherapy mai nā lāʻau hoʻomōkō pahuhopu. Hana nā lāʻau Chemotherapy ma nā hunaola āpau i ke kino e ulu wikiwiki nei, ʻaʻole wale i nā hunaola maʻi ʻaʻai. Pepehi pinepine nā lāʻau Chemotherapy i nā hunaola ulu a hoʻopili i nā hunaola i loko o ke kino ma mua o ka hana ʻana i ka hoʻomōhala.

ʻO ke ʻano laulā o Gleevec e like me ka laikini inoa inoa?

Koi ʻia ka Food and Drug Administration (FDA) i nā mea hana i nā lāʻau laulaha e hōʻoia i kā lākou huahana:

  • ka mea hana like e like me ka lāʻau lapaʻau inoa-inoa
  • ʻo ka ikaika a me ke ʻano hana like e like me ka laikini inoa inoa
  • ke ala like o ka hoʻokele (pehea ʻoe e lawe ai i ka lāʻau)

Koi ʻia ka lāʻau laulaha e hana i ke ala like a like me ka huahana inoa inoa.

Wahi a ka FDA, hoʻokō ke ʻano laulā o Gleevec i kēia mau koi. ʻO kēia ke kumu o ka hōʻoia ʻana o ka FDA i ka mana o ka generic form e like me ka lāʻau lapaʻau inoa.

Hiki iaʻu ke hoʻomohala i ke kūpaʻa ʻana me Gleevec?

Ae. Hiki iā ʻoe ke hoʻomohala i ke kūʻē iā Gleevec. ʻO ke kūpaʻa ke kumu o ka pau ʻana o ka lāʻau i ka manawa. Manaʻo ʻia ʻo kēia ke kumu o ka hoʻololi ʻana i nā genes o nā hunaola maʻi ʻaʻai.

Inā hoʻomohala ʻoe i ke kūʻē iā Gleevec, hiki i kāu kauka ke kuhikuhi i kahi lāʻau kiʻekiʻe. E ʻike lākou inā e pane hou nā hunaola maʻi ʻaʻai i ka lāʻau. E kuhikuhi paha kāu kauka i kahi lāʻau ʻokoʻa ʻē aʻe i ʻole ʻoe e kūʻē.

Aia kekahi mau papaʻai meaʻai aʻu e ukali ai i ka lawe ʻana iā Gleevec?

ʻAʻole nā ​​kapu papaʻai maʻamau e pono ai ʻoe e hāliʻi i ka lawe ʻana iā Gleevec. Eia nō naʻe, pono ʻoe e hōʻalo i ka ʻai ʻana i ka huaʻikuʻi a me ka inu ʻana i ka wai momona. Loaʻa i ka hua waina kahi kemika e hiki ke pale i kou kino mai ka metabolizing (wāwahi ʻana) Gleevec. Hiki i kēia ke alakaʻi i nā kiʻekiʻe kiʻekiʻe o ka lāʻau i kou koko. ʻO nā pae o Gleevec i ʻoi aku ka kiʻekiʻe ma mua o ka maʻamau e hoʻonui i kāu makaʻikaʻi no nā hopena ʻino.

Eia hou, hiki i kāu kauka ke hāʻawi iā ʻoe i ka ʻōlelo aʻoaʻo ākea e pili ana i kāu papaʻai e kōkua ai i ka hōʻoluʻolu ʻana i kekahi mau hopena ʻaoʻao. ʻO kahi laʻana, hana ʻo Gleevec i ka nausea a me ka luaʻi i nā poʻe he nui. I mea e pale aku ai i kēia, hiki i kāu kauka ke koi aku iā ʻoe e hōʻalo i nā meaʻai e hiki ai ke hōʻeha i ka nausea. Hoʻopili kēia i nā meaʻai kaumaha, momona, a momona paha, a me nā meaʻai nīoi a ʻākika paha. ʻO nā laʻana he nui nā mea ʻulaʻula, nā mea ʻai palai, a me nā mea ʻai wikiwiki.

ʻO ka mea hope loa, inā ʻoe e lawe iā Gleevec no kahi maʻi ʻaʻai gastrointestinal, e like me nā ʻōpū stromal gastrointestinal (GIST), hiki i kāu kauka ke koi aku i nā kapu papaʻai maʻamau. ʻO ka pahuhopu ka pale ʻana i nā pilikia i kou ʻōpū a i ʻole nā ​​ʻōpū. E kamaʻilio me kāu kauka e pili ana i nā meaʻai e pono ai nāu.

E loaʻa paha iaʻu nā ʻōuli haʻalele inā kū wau i ka hoʻohana ʻana iā Gleevec?

Hiki paha iā ʻoe. Ua loaʻa i kekahi poʻe nā ʻōuli o ka haʻalele ʻana ma hope o ka pau ʻana o kā lākou lapaʻau Gleevec. I hoʻokahi o nā noi hoʻokolohua liʻiliʻi, 30% o ka poʻe i ʻeha a i ʻole ʻeha iwi ma hope o ke kū ʻana iā Gleevec. ʻO kaʻeha ka mea pinepine i ko lākou poʻohiwi, ka pūhaka, nā wāwae, a me nā lima. Ua hana ʻia kēia hōʻailona haʻalele i loko o hoʻokahi a ʻeono pule o ka hoʻōki ʻana i ka lāʻau.

Ma kahi o ka hapalua o ka poʻe i mālama i ko lākou ʻeha me nā mea hōʻemi ʻeha o ka counter. ʻO ka hapalua e pono ai ka lāʻau lapaʻau. I ka hapanui o ka poʻe i loaʻa i kēia mau hōʻailona haʻalele, hele ka ʻeha a me ka ʻeha o ka iwi i loko o ʻekolu mau mahina i hoʻokahi makahiki a ʻoi paha.

Pono wau e hoʻohana i nā lāʻau ʻē aʻe me Gleevec no ka mālama ʻana?

Aia ia i ka holomua o kou maʻi ʻaʻai. No nā pae holomua o ka maʻi ʻaʻai a i ʻole nā ​​maʻi ʻino i hoʻolaha i ka lolo a i ʻole ka iwi kuamoʻo, hiki i kāu kauka ke hoʻohui i ka chemotherapy i kāu lapaʻau Gleevec. Hoʻohui ʻia, ʻo nā keiki me Philadelphia-positive (Ph +) leukemia lymphocytic koʻikoʻi (ALL) e loaʻa iā Gleevec me chemotherapy.

No kekahi ʻano ʻano maʻi ʻaʻai, hiki i kāu kauka ke kuhikuhi i kahi steroid. A pono paha ʻoe e hoʻohana i nā lāʻau e hoʻokele ai i nā hopena, e like me nā mea ʻeha no ka ʻehaʻeha o nā mākala.

Pau ka Gleevec, mālama, a hoʻolei

Ke kiʻi ʻoe iā Gleevec mai ka hale kūʻai lāʻau, e hoʻohui ka kauka i kahi lā palena pau i ka lepili ma ka ʻōmole. ʻO kēia lā maʻamau hoʻokahi makahiki mai ka lā a lākou i hāʻawi ai i ka lāʻau.

Kōkua ka lā palena i ka hōʻoia ʻana i ka maikaʻi o nā lāʻau i kēia manawa. ʻO ke kūlana o ka Food and Drug Administration (FDA) i kēia manawa e hōʻalo i ka hoʻohana ʻana i nā lāʻau i make. Inā loaʻa iā ʻoe kahi lāʻau i hoʻohana ʻole ʻia i hala i ka lā palena pau, e kamaʻilio me kāu kauka lāʻau. Hiki iā lākou ke haʻi iā ʻoe inā paha hiki iā ʻoe ke hoʻohana.

Waihona

Pehea ka lōʻihi o ka maikaʻi o ka lāʻau e hiki ai ke hilinaʻi i nā kumu he nui, e like me pehea a ma hea ʻoe e mālama ai i ka lāʻau.

E mālama i kāu mau pila Gleevec ma ke ana wela o ka lumi i loko o kahi pahu paʻa paʻa. E pale pono iā lākou mai ka pulu.

Hoʻolei

Inā ʻaʻole pono ʻoe e lawe hou iā Gleevec a loaʻa nā lāʻau i koe, he mea nui ia e hoʻolei aku me ka palekana.

Kōkua kēia i ka pale aku i nā poʻe ʻē aʻe, e like me nā keiki a me nā holoholona, ​​mai ka lawe lāʻau ʻana ʻole. Mālama pū kekahi ia i ka lāʻau mai hōʻino i ke kaiapuni.

Hāʻawi ka pūnaewele FDA i nā ʻōlelo aʻoaʻo e pili ana i ka hoʻolāʻau lāʻau. Hiki iā ʻoe ke nīnau i kāu kauka lāʻau no ka ʻike e pili ana i ka hoʻolilo ʻana i kāu lāʻau.

ʻO ka ʻike ʻoihana no Gleevec

Hāʻawi ʻia ka ʻike aʻe no nā kauka lapaʻau a me nā ʻoihana ola.

Nā Hōʻike

Ua ʻae ʻia ʻo Gleevec (imatinib) e mālama i kēia mau mea:

  • nā mākua a me nā keiki me ka ʻike hou ʻia ʻo Philadelphia-positive (Ph +) leukemia myeloid mau (CML) i ka wā mau
  • nā mākua me Ph + CML i kēlā me kēia pae, ma hope o ka holo pono ʻole o interferon-alpha therapy
  • makua me ka relapsed a refactory Ph + huehue lymphocytic leukemia (ALL)
  • nā keiki me Ph + ALL hou i ʻike ʻia me ka chemotherapy
  • makua me ka myelodysplastic / myeloproliferative maʻi e pili ana me ka platelet-ulu ulu receptor gen hoʻoponopono hou
  • makua me ka mastocytosis ʻōnaehana kolohe me ka ʻole o ka mutation D816V c-Kit a i ʻole me ke kūlana mutation c-Kit i ʻike ʻole ʻia.
  • nā mākua me ka hypereosinophilic syndrome a me / a i ʻole leukemia eosinophilic mau me FIP1L1-PDGFRα fusion kinase, maikaʻi ʻole no ka FIP1L1-PDGFRα kinase fusion, a i ʻole kūlana ʻike ʻole ʻia.
  • makua me ka unresectable, recurrent, a metastatic dermatofibrosarcoma protuberans (DFSP)
  • mākua me ka unresectable a metastatic malignant kini puʻe wale + gastrointestinal stromal hikoko (GIST)
  • adjuvant therapy no nā mākua me Kit + GIST e ukali nei i ka hoʻopau piha loa

Mekanism o ka hana

Hoʻopili ʻo Gleevec i ka BCR-ABL tyrosine kinase, ʻo ia ka tyrosine kinase maʻamau i loaʻa ma Ph + CML. Ke kāohi nei i ka BCR-ABL tyrosine kinase e pale i ka hoʻonui ʻana o ka cellular a hoʻokomo i ka apoptosis i nā laina pūnaewele BCR-ABL a i nā laina leukemikō. Pākuʻi ʻo Gleevec i nā kinases tyrosine no ka mea ulu ulu i loaʻa i ka platelet (PDGF) a me ka pūnaehana cell stem (SCF) a me c-Kit, ka mea e kāohi i ka hoʻonui a hoʻokomo i ka apoptosis i nā pūnaewele GIST.

Pharmacokinetics a me ka metabolism

ʻO ke kumu ʻo bioavailability paʻa he 98% ma hope o ka hoʻoponopono waha. Ma kahi o 95% o ka hopena i hoʻopaʻa ʻia i nā protein plasma (ʻo ka hapa nui albumin a me α1-acid glycoprotein).

Kū ka Metabolism ma o CYP3A4 i kahi metabolite hana, me ka metabolism liʻiliʻi e loaʻa ana ma o CYP1A2, CYP2D6, CYP2C9, a me CYP2C19. Hoʻokumu mua ʻia ka metabolite hana e kaʻapuni nei e CYP3A4. Ma kahi o 68% hoʻopau ʻia i nā feces, me 13% i ka mimi. ʻO ka hapalua o ka hoʻopau ʻana o ka lāʻau i hoʻololi ʻole ʻia he 18 mau hola a me ka hoʻopau ʻana i ka hapalua o ke ola o ka metabolite hana nui he 40 mau hola.

Nā Kūʻai Kūʻai

ʻAʻohe contraindications loa i ka hoʻohana ʻana o Gleevec.

Ka mālama a me ka lawelawe ʻana

Pono e mālama ʻia nā papa Gleevec i ka mahana wela (77 ° F / 25 ° C) i loko o kahi pahu paʻa paʻa. Palekana papa mai ka ona.

Manaʻo ʻia ʻo nā papa ʻo Gleevec he mea weliweli ia, e like me nā kūlana palekana o ka Health and Health Administration (OSHA). ʻAʻole pono e haki i nā papa. Hōʻalo i ka hoʻopili ʻana i nā papa i wāwahi ʻia. Inā pili ka ʻili a me nā membrane mucus i nā papa i wāwahi ʻia, holoi i kahi i hoʻopili ʻia e like me ke alakaʻi ʻana a OSHA.

Hoʻolaha: Ua hana ʻo Nūhou Lapaʻau i kēia mau lā e hōʻoia i ka pololei, ka laulā, a me ka lā hou o nā ʻike āpau. Eia nō naʻe, ʻaʻole pono e hoʻohana i kēia ʻatikala i pani no ka ʻike a me ka mākaukau o kahi loea mālama ola laikini. E nīnau mau ʻoe i kāu kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka lawe ʻana i nā lāʻau. Hiki ke loli i ka ʻike o ka lāʻau i loko a ʻaʻole i manaʻo ʻia e uhi i nā hoʻohana a pau, nā kuhikuhi, ka mālama ʻana, nā ʻōlelo aʻoaʻo, nā launa lāʻau, nā hopena maʻi ʻaʻai, a me nā hopena maikaʻi ʻole. ʻO ka loaʻa ʻole o nā ʻōlelo aʻoaʻo a i ʻole nā ​​ʻike ʻē aʻe no kahi lāʻau i hāʻawi ʻia ʻaʻole ia e hōʻike i ka palekana o ka lāʻau a lāʻau paha i kūpono no nā mea maʻi āpau a i ʻole nā ​​hoʻohana kikoʻī āpau.

Hoihoi

Hōʻike Diabetes Gestational: He aha ka mea e manaʻo ai
Ola Kino

Hōʻike Diabetes Gestational: He aha ka mea e manaʻo ai

He aha ka mimikō hānau?ʻO ka maʻi diabete Ge tational2428prenatal mālama Nui nā wahine i loaʻa ʻole i ka maʻi diabete . Inā kū mai nā ʻōuli, hiki paha ke nānā ʻole iā lākou no ka mea like lākou me nā...
ʻO Cerstic Dystonia
Ola Kino

ʻO Cerstic Dystonia

Hōʻike OverviewʻO ka cer tic dy tonia kahi ʻano maʻamau kahi e aelike ʻole ai nā ʻāʻī o kou ʻāʻī i nā kūlana kūpono ʻole. Kuhi ia i ka neʻe ʻana o ka neʻe ʻana o kou poʻo a me kou ʻāʻī. Hiki ke neʻe ...